Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3023430	s-kisshie	— (—)	3108	3199	100.00%	Distribution not available
3023430	s-kisshie	u/ml (u/ml)	2710	2886	2.53%
3023430	kissa	— (—)	612	643	100.00%	Distribution not available
3023430	kissa	u/ml (u/ml)	146	150	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma, hospital admissions , main diagnosis only

1787

4430

3.71

307.65

1.1

1.0

6.76

4.62

u/ml

3.30

1027

1660

Asthma-related infections

1078

2938

3.70

307.65

1.1

1.0

7.04

4.78

u/ml

2.47

631

1118

Asthma (only as main-diagnosis), excluding more controls

1705

2146

4.88

307.65

1.1

1.0

6.18

4.91

u/ml

1.16

968

728

Vasomotor and allergic rhinitis

1345

2394

5.85

307.65

1.1

1.0

7.53

5.47

u/ml

2.00

785

919

Asthma (only as main-diagnosis)

1706

2163

4.90

307.65

1.1

1.0

6.18

4.85

u/ml

1.25

968

737

Allergic asthma (mode), excluding more controls

870

1349

6.69

307.65

1.1

1.0

8.16

5.38

u/ml

2.25

599

480

Chronic lower respiratory diseases

2395

3985

3.32

307.65

1.1

1.0

6.56

4.30

u/ml

4.39

1281

1448

Asthma and allergy, excluding more controls

634

848

8.01

307.65

1.1

1.0

9.37

5.60

u/ml

2.39

445

313

Allergic rhinitis

1267

2333

5.75

307.65

1.1

1.0

7.62

5.25

u/ml

2.43

757

910

Asthma (diagnoses ohter than nonallergic)

1830

4324

3.72

307.65

1.1

1.0

6.88

4.62

u/ml

3.63

1056

1610

Allergic asthma (mode)

870

1348

6.69

307.65

1.1

1.0

8.16

5.37

u/ml

2.26

599

479

Asthma, excluding more controls

1809

2146

4.62

307.65

1.1

1.0

5.94

4.91

u/ml

0.90

1011

728

Asthma/COPD (KELA code 203)

1869

3947

3.41

307.65

1.1

1.0

6.97

4.21

u/ml

5.04

1020

1434

Pollen allergy

978

1632

6.52

307.65

1.1

7.24

5.41

u/ml

1.28

588

674

Asthma

1820

2163

4.64

307.65

1.1

1.0

5.92

4.85

u/ml

0.96

1015

737

Asthma and allergy

634

836

8.13

307.65

1.1

1.0

9.37

5.60

u/ml

2.37

445

306

Asthma, including avohilmo

2632

3759

4.18

307.65

1.1

1.0

6.51

4.06

u/ml

5.36

1373

1358

Asthma (mode)

1815

2169

4.73

307.65

1.1

1.0

5.93

4.84

u/ml

1.00

1016

740

Asthma, hospital admission 2, infections

1078

2938

3.70

307.65

1.1

1.0

7.04

4.78

u/ml

2.47

631

1118

937

2484

3.86

301.96

1.1

1.0

7.45

4.94

u/ml

2.43

546

965

Asthma, unspecified (mode)

832

1784

3.77

245.75

1.1

1.0

4.56

4.62

u/ml

0.03

389

608

Asthma, unspecified (mode), excluding more controls

830

1777

3.74

241.74

1.1

1.0

4.58

4.65

u/ml

0.04

387

604

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1106

3738

2.98

236.85

1.1

5.03

5.18

u/ml

0.10

615

1448

Allergic conjunctivitis

1144

3975

2.90

233.46

1.1

5.17

5.36

u/ml

0.12

642

1549

Conjunctivitis

1356

4653

2.59

217.11

1.1

5.30

5.78

u/ml

0.40

735

1863

Atopic dermatitis

1220

3928

2.71

212.39

1.1

8.72

4.50

u/ml

7.26

689

1535

Chronic sinusitis

701

1970

3.64

209.66

1.1

1.0

3.43

4.45

u/ml

0.85

314

696

Other diseases of upper respiratory tract

1537

3210

2.53

205.87

1.1

1.0

5.85

5.17

u/ml

0.44

750

1217

Disorders of conjunctiva

1384

4738

2.49

202.74

1.1

5.23

5.72

u/ml

0.42

747

1898

Desensitization to allergens

309

492

7.09

189.65

1.1

1.0

7.29

5.46

u/ml

0.70

201

216

Dermatitis and eczema

1584

4720

2.23

171.91

1.1

1.0

7.66

4.13

u/ml

6.84

833

1841

Chronic rhinitis, nasopharyngitis and pharyngitis

536

1448

3.80

170.48

1.1

1.0

3.68

4.81

u/ml

0.73

245

531

Obesity related asthma

497

1289

3.95

167.52

1.1

1.0

5.98

3.45

u/ml

1.30

252

417

Suggestive for eosinophilic asthma

198

226

9.20

159.76

1.2

1.0

3.39

3.54

u/ml

0.04

131

Atopic dermatitis, strict definition with reimbursement

744

2586

2.88

147.98

1.1

10.06

5.04

u/ml

6.06

488

1054

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

682

2279

2.98

147.44

1.1

1.0

3.69

4.32

u/ml

0.45

314

822

Nasal polyp

288

553

5.35

141.89

1.1

1.0

3.43

3.27

u/ml

0.06

163

188

Other pulmonary diagnosis

1073

2202

2.47

135.73

1.1

1.0

4.49

4.82

u/ml

0.20

498

757

ILD differential diagnosis

1056

2169

2.47

133.31

1.1

1.0

4.49

4.84

u/ml

0.22

491

740

COPD differential diagnosis

1056

2170

2.46

133.20

1.1

1.0

4.49

4.94

u/ml

0.30

491

741

Excluding asthma or asthma-COPD overlap

1057

2202

2.43

129.64

1.1

1.0

4.47

4.82

u/ml

0.22

492

757

Childhood asthma (age<16), excluding more controls

416

944

3.63

114.83

1.1

1.0

10.09

6.18

u/ml

2.11

285

367

Childhood asthma (age<16)

416

946

3.62

114.55

1.1

1.0

10.09

6.16

u/ml

2.12

285

368

Oral corticosteroids

1378

4193

2.01

113.17

1.1

1.0

5.61

4.58

u/ml

1.09

692

1617

Undetermined asthma

214

389

5.66

112.05

1.1

1.0

3.39

4.95

u/ml

0.58

103

128

Atopic dermatitis, strict definition

707

2792

2.55

111.86

1.1

10.45

5.53

u/ml

5.54

464

1173

Undetermined asthma, excluding more controls

214

390

5.65

111.74

1.1

1.0

3.39

4.99

u/ml

0.59

103

127

ILD medications: prednisolone, methylprednisolone, prednisone

1471

4288

1.96

110.58

1.1

1.0

5.47

5.02

u/ml

0.36

725

1704

Cough

555

1957

2.77

104.41

1.1

6.10

5.58

u/ml

0.15

252

822

Diseases of the respiratory system

783

1618

2.45

97.89

1.1

1.0

4.54

4.82

u/ml

0.13

347

546

Asthma-related pneumonia or sepsis

388

1222

3.22

96.84

1.1

1.0

4.65

4.92

u/ml

0.11

247

434

Asthma, hospital admissions 3, pneumonia

388

1222

3.22

96.84

1.1

1.0

4.65

4.92

u/ml

0.11

247

434

Asthma-related pneumonia

386

1217

3.22

96.18

1.1

1.0

4.65

4.94

u/ml

0.12

247

432

FESS (DNB20)

251

598

4.36

95.77

1.1

2.25

4.15

u/ml

1.34

125

229

Ethmoidectomy

254

623

4.23

93.22

1.1

1.0

2.21

4.04

u/ml

1.31

127

236

Deviated nasal septum

360

1128

3.24

90.80

1.1

1.0

4.00

u/ml

0.00

166

383

ILD medications

1481

4539

1.81

86.96

1.1

1.0

5.42

5.33

u/ml

0.06

732

1845

Abnormalities of breathing

1259

4008

1.88

85.94

1.1

5.86

5.46

u/ml

0.19

555

1688

Inflammatory bowel disease treatment related agents

1442

4654

1.77

80.62

1.1

5.58

4.96

u/ml

0.57

716

1856

Symptoms and signs involving the circulatory and respiratory systems

1410

4054

1.76

74.14

1.1

5.76

5.45

u/ml

0.15

627

1711

First line medication for Crohn's disease

1418

4494

1.73

72.76

1.1

1.0

5.74

5.19

u/ml

0.46

696

1835

Chronic diseases of tonsils and adenoids

956

3165

1.93

71.27

1.1

1.0

5.68

5.23

u/ml

0.21

425

1201

Acute upper respiratory infections

1207

4358

1.75

65.80

1.1

5.72

5.16

u/ml

0.32

554

1798

Childhood allergy (age < 16)

459

1599

2.45

63.74

1.1

12.00

6.35

u/ml

4.00

310

739

Biological medicines for asthma

12.80

58.90

1.2

1.0

9.62

4.30

u/ml

1.01

Acute sinusitis

702

3542

1.87

51.25

1.1

4.52

4.92

u/ml

0.25

309

1449

Other medical care

366

1528

2.36

50.59

1.1

6.87

4.37

u/ml

1.52

217

606

Dermatitis due to ingested food

153

395

4.02

50.27

1.1

12.83

8.22

u/ml

1.17

111

198

Acute upper respiratory infections of multiple and unspecified sites

938

4118

1.72

50.27

1.1

6.75

5.24

u/ml

0.94

426

1707

Dyspnoea

881

3894

1.75

49.95

1.1

5.59

4.70

u/ml

0.44

394

1589

Adverse effects, not elsewhere classified

327

1349

2.48

49.64

1.1

6.71

5.75

u/ml

0.36

202

581

1232

4055

1.61

48.36

1.1

1.0

5.69

5.05

u/ml

0.38

562

1628

Bronchitis

1187

4912

1.59

46.42

1.1

5.90

4.97

u/ml

0.63

546

2025

Urticaria

440

2160

2.07

43.63

1.1

5.13

5.70

u/ml

0.23

230

917

Urticaria and erythema

487

2532

1.95

40.95

1.1

5.78

5.61

u/ml

0.06

253

1072

Non-allergic asthma (mode), excluding more controls

191

657

2.92

40.61

1.1

1.0

4.88

5.19

u/ml

0.06

225

Non-allergic asthma (mode)

191

658

2.91

40.51

1.1

1.0

4.88

5.16

u/ml

0.05

226

Personal history of allergy to drugs, medicaments and biological substances

10.69

40.23

1.4

1.0

2.34

4.64

u/ml

0.43

Diseases of the skin and subcutaneous tissue

1166

3766

1.56

39.56

1.1

1.0

6.66

3.93

u/ml

3.31

569

1446

Sleep apnoea, including avohilmo

910

3638

1.63

39.29

1.1

3.60

4.21

u/ml

0.55

366

1477

Chronic laryngitis and laryngotracheitis

131

385

3.46

37.07

1.1

1.0

3.23

3.31

u/ml

0.02

125

Diseases of the eye and adnexa

1144

3754

1.54

36.11

1.1

6.23

5.65

u/ml

0.31

561

1494

Any reimbursement code in KELA

956

3068

1.57

33.51

1.1

1.0

7.58

4.43

u/ml

2.64

484

1148

Early onset COPD, excluding more controls

129

407

3.20

32.49

1.1

1.0

7.43

3.92

u/ml

0.77

125

D07AA Corticosteroids, weak (group I)

272

1250

2.22

32.28

1.1

13.02

6.22

u/ml

3.31

191

553

Other and unspecified effects of external causes

389

2044

1.93

31.92

1.1

6.66

5.73

u/ml

0.39

224

891

Voice disturbances

255

1167

2.21

30.46

1.1

3.45

3.64

u/ml

0.07

110

447

Asthma mixed form (mode)

164

4.56

30.19

1.1

1.0

5.55

4.29

u/ml

0.25

Asthma mixed form (mode), excluding more controls

164

4.55

30.19

1.1

1.0

5.55

4.29

u/ml

0.25

Gastro-oesophageal reflux disease

604

3229

1.67

30.08

1.1

3.46

4.80

u/ml

1.15

235

1305

Migraine, single triptan purchase ok & required. ICD-code if available is included

973

4405

1.51

29.86

1.1

7.12

5.04

u/ml

1.11

387

1892

Triptan medication for migraine, single purchase ok

973

4405

1.51

29.86

1.1

7.12

5.04

u/ml

1.11

387

1892

Polypectomy (DHB20)

207

4.06

29.17

1.2

1.1

1.72

2.79

u/ml

0.76

COPD/asthma related infections

1130

3872

1.47

29.04

1.1

1.0

5.86

5.04

u/ml

0.49

498

1574

COPD/asthma/ILD related infections

1130

3872

1.47

29.04

1.1

1.0

5.86

5.04

u/ml

0.49

498

1574

Bronchiectasis

5.78

28.97

1.1

1.0

1.59

2.47

u/ml

0.26

Sleep apnoea

790

3470

1.55

28.09

1.1

3.68

4.08

u/ml

0.29

317

1393

Other acute lower respiratory infections

532

3063

1.67

26.96

1.1

7.33

5.68

u/ml

0.73

274

1345

Migraine

676

3671

1.58

26.80

1.1

7.66

5.45

u/ml

0.80

272

1555

Asthma and opportunity respiratory infection

6.47

26.15

1.1

1.0

1.64

2.50

u/ml

0.21

Symptoms and signs involving speech and voice

275

1384

2.01

25.60

1.1

4.14

3.48

u/ml

0.28

122

532

Episodal and paroxysmal disorders

1254

4612

1.40

25.10

1.1

6.26

5.31

u/ml

0.55

552

2002

Recurrent or chronic depression

515

2255

1.66

24.60

1.1

6.51

4.76

u/ml

0.60

218

954

Malignant neoplasm

361

3711

0.57

23.42

1.0

1.1

3.17

4.27

u/ml

0.75

129

1498

Coxibs

293

794

1.98

23.12

1.1

6.74

5.62

u/ml

0.37

112

375

Pain in joint

632

2699

1.56

22.95

1.1

5.91

5.18

u/ml

0.28

294

1158

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

394

3899

0.59

22.36

1.0

1.1

3.03

4.39

u/ml

1.17

144

1587

Malignant neoplasm, wide definition for exclusion

394

3899

0.59

22.36

1.0

1.1

3.03

4.39

u/ml

1.17

144

1587

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

395

3903

0.60

22.28

1.0

1.1

3.03

4.41

u/ml

1.20

144

1591

Headache

754

4284

1.48

22.26

1.1

7.35

5.37

u/ml

0.98

307

1815

Other and unspecified urticaria

257

1331

1.96

22.24

1.1

5.08

5.81

u/ml

0.22

129

547

Depression or dysthymia

694

2562

1.52

22.01

1.1

6.14

4.55

u/ml

0.76

303

1082

Diabetes, insulin treatment (Kela reimbursement)

427

4258

0.61

21.78

1.1

5.87

4.39

u/ml

0.70

189

1751

Conjunctivitis (acute, non atopic)

308

1709

1.81

21.20

1.1

6.67

6.63

u/ml

0.01

153

714

Dermatitis

489

3080

1.60

21.08

1.1

4.89

3.78

u/ml

0.65

241

1170

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

423

4175

0.62

20.82

1.1

5.93

4.37

u/ml

0.74

187

1714

COPD

165

609

2.24

20.12

1.1

1.0

6.44

2.81

u/ml

1.05

193

Sleep disorders (combined)

912

4260

1.41

20.08

1.1

3.77

5.03

u/ml

1.40

380

1762

Any event in cancer register

454

4248

0.63

20.07

1.1

3.37

4.64

u/ml

1.01

163

1735

Diabetes medication

517

4805

0.65

19.79

1.1

5.54

4.59

u/ml

0.47

229

1974

Diabetes mellitus

536

4847

0.66

19.60

1.1

6.40

4.62

u/ml

0.96

242

1985

Diabetes, varying definitions

530

4806

0.66

19.53

1.1

6.37

4.61

u/ml

0.91

237

1969

Other chronic obstructive pulmonary disease

155

570

2.27

19.49

1.1

1.0

6.82

2.72

u/ml

1.15

181

Acute bronchitis

351

2046

1.69

19.05

1.1

5.22

5.37

u/ml

0.05

169

871

Dermatographic urticaria

105

404

2.66

18.87

1.1

2.14

3.92

u/ml

1.21

153

Atopic conjunctivitis

242

3.15

17.99

1.1

7.53

6.07

u/ml

0.27

101

Triptan medication for migraine, min. 3 purchases

726

4042

1.43

17.66

1.1

6.62

5.11

u/ml

0.65

281

1680

Abnormal findings on diagnostic imaging of lung

230

1204

1.87

17.64

1.1

1.0

4.17

2.96

u/ml

0.46

449

Idiopathic urticaria

107

4.40

17.61

1.2

1.1

6.12

6.76

u/ml

0.06

Irritable bowel syndrome

289

1672

1.74

17.54

1.1

4.73

5.00

u/ml

0.08

112

687

Acetic acid derivatives and related substances

270

767

1.85

17.46

1.1

4.72

5.23

u/ml

0.16

103

361

Special screening examination for infectious and parasitic diseases

406

1905

1.61

17.24

1.1

1.0

5.45

5.57

u/ml

0.04

175

765

Temporomandibular joint disorders, including avohilmo

526

3540

1.50

16.88

1.1

4.70

5.71

u/ml

0.57

252

1474

Abnormalities of heart beat

282

1624

1.73

16.79

1.1

7.36

4.68

u/ml

0.55

118

652

Pain (limb, back, neck, head abdominally)

793

2845

1.40

16.27

1.1

6.77

5.53

u/ml

0.57

346

1254

Allergic contact dermatitis

155

754

2.08

16.16

1.1

6.17

3.04

u/ml

1.24

267

Type 2 diabetes

466

4111

0.67

15.55

1.1

5.94

3.84

u/ml

1.10

209

1623

Renal tubulo-interstitial diseases

357

4273

0.64

15.54

1.1

5.35

5.14

u/ml

0.07

151

1795

Disorders of lacrimal system

317

1944

1.64

15.47

1.1

4.70

4.33

u/ml

0.14

125

753

Propionic acid derivatives

316

944

1.69

15.25

1.1

7.44

6.79

u/ml

0.16

137

474

Other disorders of lacrimal gland

263

1543

1.72

15.22

1.1

4.90

3.87

u/ml

0.41

102

605

Other and unspecified dermatitis

393

2553

1.55

15.01

1.1

1.0

4.30

3.79

u/ml

0.26

193

974

Pain in throat and chest

791

3533

1.37

14.99

1.1

4.24

5.19

u/ml

0.72

315

1464

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

494

1655

1.51

14.70

1.1

1.0

5.58

5.52

u/ml

0.02

211

732

Tonsillectomy and adenotomy

822

4267

1.35

14.19

1.1

6.08

5.82

u/ml

0.10

370

1869

Other (not insulin) diabetes medications

418

3751

0.67

14.16

1.1

4.99

3.88

u/ml

0.49

180

1472

Eosinophilic disease (BM)

6.89

14.12

1.2

1.0

1.42

2.74

u/ml

—

Schizophrenia

1057

0.23

14.06

1.1

8.43

4.05

u/ml

—

444

Low back pain

709

3989

1.37

14.05

1.1

5.07

4.72

u/ml

0.16

293

1655

Biguanides

391

3614

0.66

13.82

1.1

4.72

3.93

u/ml

0.31

163

1421

Anxiety disorders

947

5127

1.31

13.75

1.1

6.71

4.86

u/ml

1.07

426

2143

Neurotic, stress-related and somatoform disorders

943

5120

1.31

13.72

1.1

6.71

4.88

u/ml

1.04

423

2140

Neurological diseases

1040

4025

1.31

13.57

1.1

7.13

5.46

u/ml

0.94

466

1779

Temporomandibular joint disorders

185

1017

1.84

13.52

1.1

1.0

3.33

4.83

u/ml

0.66

423

Codeine

977

4109

1.31

13.39

1.1

5.59

4.80

u/ml

0.40

412

1685

Type 2 diabetes, strict (exclude DM1)

422

3696

0.68

13.28

1.1

6.35

3.65

u/ml

1.34

187

1444

Pain and other conditions associated with female genital organs and menstrual cycle

291

1744

1.62

13.27

1.1

4.94

6.16

u/ml

0.34

111

757

Other headache syndromes

402

2703

1.50

13.16

1.1

8.77

4.45

u/ml

1.22

168

1081

Exposure to unspecified factor

927

5527

1.31

13.07

1.1

5.49

5.40

u/ml

0.04

429

2343

Type 2 diabetes, definitions combined

423

3687

0.68

13.02

1.1

6.32

3.62

u/ml

1.35

188

1442

Other bacterial diseases

406

4120

0.68

13.01

1.1

5.30

5.05

u/ml

0.09

186

1724

Early onset COPD

129

636

2.04

13.00

1.1

1.0

7.43

2.75

u/ml

1.29

243

Schizophrenia, schizotypal and delusional disorders

111

2242

0.49

12.84

1.1

6.63

4.81

u/ml

0.34

950

Schizophrenia or delusion

111

2238

0.49

12.78

1.1

6.63

4.82

u/ml

0.34

947

Anxiety disorders, excluding more controls

864

4361

1.32

12.77

1.1

6.45

4.75

u/ml

0.85

383

1784

Codeine or tramadol medication

1070

4632

1.28

12.55

1.1

5.61

4.61

u/ml

0.58

438

1891

Other dorsopathies, not elsewhere classified

1058

4358

1.28

12.42

1.1

6.46

5.01

u/ml

0.95

462

1844

Abdominal and pelvic pain

1015

3958

1.29

12.41

1.1

5.31

5.76

u/ml

0.24

428

1735

Type 2 diabetes, definitions combined, including avohilmo

442

3755

0.69

12.36

1.1

5.76

3.70

u/ml

1.01

197

1465

Simple and mucopurulent chronic bronchitis

4.40

12.17

1.0

1.1

1.72

4.33

u/ml

0.42

Opioids

1042

4276

1.28

12.13

1.1

5.77

4.98

u/ml

0.43

446

1771

Parasetamol

928

3647

1.30

12.07

1.1

5.48

5.43

u/ml

0.02

396

1551

ILD, hospital admissions 1, main diag only

225

2.73

11.95

1.0

1.1

1.56

3.62

u/ml

0.93

Anti-inflammatory and antirheumatic products, non-steroids

299

945

1.60

11.74

1.1

7.25

6.86

u/ml

0.09

127

475

Haemorrhage from respiratory passages

175

915

1.78

11.64

1.1

1.0

4.02

4.66

u/ml

0.21

355

Acute pharyngitis

204

1203

1.70

11.51

1.1

7.55

6.71

u/ml

0.18

542

Insulin medication

203

2861

0.60

11.47

1.1

6.05

4.71

u/ml

0.44

1214

Diseases of middle ear and mastoid

678

4175

1.34

11.41

1.1

6.35

5.93

u/ml

0.15

318

1852

Migraine with aura

299

1952

1.54

11.40

1.1

9.50

5.12

u/ml

0.89

131

821

ILD, hospital admissions

254

2.58

11.38

1.0

1.1

1.56

3.32

u/ml

0.84

102

Other interstitial pulmonary diseases

254

2.58

11.38

1.0

1.1

1.56

3.32

u/ml

0.84

102

Soft tissue disorders related to use, overuse and pressure

185

1072

1.74

11.35

1.1

3.51

3.39

u/ml

0.05

392

Other respiratory diseases principally affecting the interstitium

320

2.39

11.35

1.0

1.1

2.00

2.81

u/ml

0.35

131

Interstitial lung disease endpoints

255

2.57

11.29

1.0

1.1

1.56

3.32

u/ml

0.84

102

Interstitial lung disease

255

2.57

11.29

1.0

1.1

1.56

3.32

u/ml

0.84

102

Other diseases of hard tissues of teeth

614

3388

1.36

11.29

1.1

3.89

5.65

u/ml

1.73

289

1395

Schizophrenia or delusion, excluding more controls

111

2127

0.51

11.26

1.1

6.63

4.42

u/ml

0.44

879

All anxiety disorders

737

4521

1.32

11.25

1.1

6.10

5.05

u/ml

0.63

335

1902

Other special examinations and investigations of persons without complaint or reported diagnosis

691

2615

1.34

11.08

1.1

1.0

5.99

5.80

u/ml

0.08

320

1051

Symptoms and signs involving the digestive system and abdomen

1003

3959

1.27

10.93

1.1

4.67

5.76

u/ml

1.10

421

1736

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1150

0.40

10.75

1.0

1.1

1.36

3.27

u/ml

2.12

443

Other antidepressants

963

3953

1.27

10.69

1.1

6.86

4.68

u/ml

1.34

427

1654

Oxicams

161

502

1.83

10.69

1.0

1.1

3.72

3.50

u/ml

0.06

234

Eosinophilia

5.16

10.60

1.2

1.0

1.42

7.66

u/ml

—

Diseases of the musculoskeletal system and connective tissue

745

2852

1.32

10.44

1.1

6.61

5.80

u/ml

0.33

345

1258

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

146

1659

0.57

10.09

1.0

1.1

2.69

3.46

u/ml

0.32

610

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

146

1659

0.57

10.09

1.0

1.1

2.69

3.46

u/ml

0.32

610

Fenamates

128

454

1.91

10.09

1.1

4.87

3.90

u/ml

0.20

206

Mental and behavioural disorders due to alcohol, excluding acute intoxication

137

2399

0.57

10.02

1.1

5.33

4.60

u/ml

0.17

979

Dorsopathies

1082

4439

1.25

10.01

1.1

6.19

5.15

u/ml

0.64

473

1890

Alcohol use disorder, ICD-based

125

2237

0.56

9.86

1.1

5.46

4.67

u/ml

0.17

916

Heartburn

460

2.07

9.84

1.0

1.1

2.91

3.44

u/ml

0.14

195

Anxiety (asthma-related co-morbidities)

713

4348

1.30

9.81

1.1

5.76

4.97

u/ml

0.45

320

1813

Medical observation and evaluation for suspected diseases and conditions

672

2615

1.32

9.76

1.1

1.0

5.50

5.80

u/ml

0.13

326

1051

Type 2 diabetes, wide definition

260

2558

0.66

9.74

1.1

4.63

3.53

u/ml

0.45

115

971

Dorsalgia

990

4292

1.25

9.64

1.1

6.12

4.98

u/ml

0.64

418

1806

Kela-code for severe mental illness

149

2525

0.59

9.63

1.1

5.51

4.60

u/ml

0.21

1056

Migraine with aura and triptan purchases

205

1284

1.61

9.51

1.1

11.01

4.77

u/ml

0.89

557

Dental caries 2, only avohilmo

815

5082

1.27

9.42

1.1

6.11

5.54

u/ml

0.33

371

2142

Parodontitis or/and operation codes

332

2823

0.70

9.30

1.0

1.1

4.35

3.72

u/ml

0.32

146

1171

Bronchitis, not specified as acute or chronic

262

2.39

9.29

1.0

7.80

3.53

u/ml

0.75

Allergic urticaria

103

533

1.96

9.29

1.2

1.1

8.96

5.31

u/ml

0.63

226

Other and unspecified nonorganic psychotic disorders

1603

0.49

9.24

1.1

7.73

5.33

u/ml

0.32

690

Soft tissue disorders

1087

4589

1.23

9.18

1.1

5.38

5.64

u/ml

0.13

472

1994

Paracetamol of NSAID medication

220

693

1.61

9.00

1.1

6.04

7.01

u/ml

0.29

365

Malignant neoplasm of breast

142

1736

0.59

9.00

1.0

1.1

2.69

3.27

u/ml

0.23

625

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

236

2.26

8.99

1.0

1.57

2.98

u/ml

0.87

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

343

2235

1.43

8.95

1.1

3.38

4.12

u/ml

0.38

147

874

Myalgia

215

1381

1.57

8.93

1.1

6.63

5.24

u/ml

0.20

559

STROKE

181

1999

0.63

8.81

1.1

3.40

3.45

u/ml

0.02

758

Other joint disorders

1016

4392

1.24

8.78

1.1

6.57

5.41

u/ml

0.59

456

1877

Other specific joint derangements/joint disorders

798

4246

1.26

8.76

1.1

5.73

5.45

u/ml

0.11

348

1801

Gastrointestinal diseases

791

3123

1.27

8.76

1.1

5.23

6.07

u/ml

0.40

346

1386

Other and unspecified tonsillitis

444

2776

1.36

8.74

1.1

5.99

5.80

u/ml

0.06

191

1215

Alcohol use disorder, Swedish definition

200

2869

0.64

8.71

1.1

4.94

4.50

u/ml

0.14

1183

Other chronic obstructive pulmonary disease, including avohilmo

208

1101

1.58

8.69

1.1

1.0

5.78

3.06

u/ml

0.97

105

422

Dental caries 2

817

5129

1.26

8.67

1.1

5.89

5.59

u/ml

0.15

372

2167

Cerebrovascular diseases

162

1887

0.61

8.66

1.0

1.1

4.23

3.24

u/ml

0.33

723

COPD (mode)

355

2.02

8.65

1.1

1.0

7.34

3.99

u/ml

0.49

112

Insulin, combination of fast acting with intermediate-acting or long-acting

203

2873

0.65

8.57

1.1

6.05

4.73

u/ml

0.43

1224

Dentofacial anomalies [including malocclusion]

311

2154

1.44

8.48

1.1

3.57

6.50

u/ml

3.02

143

908

Dental caries 2 and operation codes

803

5104

1.25

8.45

1.1

5.93

5.60

u/ml

0.16

362

2155

Neurological diseases, wide definition

488

1819

1.35

8.38

1.1

7.79

5.78

u/ml

0.54

214

851

Suppurative and unspecified otitis media

480

3199

1.34

8.36

1.1

6.74

6.38

u/ml

0.10

238

1468

Selective serotonin reuptake inhibitors

942

4013

1.24

8.36

1.1

6.24

4.76

u/ml

0.87

401

1700

Substance abuse

249

3485

0.68

8.33

1.1

6.56

4.94

u/ml

0.66

126

1449

Diseases of the ear and mastoid process

1177

4929

1.21

8.33

1.1

5.82

5.33

u/ml

0.27

524

2076

Acute bronchiolitis

124

634

1.79

8.29

1.1

14.68

9.59

u/ml

0.67

349

COPD, hospital admissions

155

789

1.67

8.19

1.1

1.0

6.74

2.70

u/ml

1.19

296

COPD, early/later onset

156

794

1.66

8.17

1.1

1.0

6.74

2.68

u/ml

1.20

298

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

201

1302

1.56

8.13

1.1

7.38

5.44

u/ml

0.47

545

254

3306

0.69

8.13

1.1

4.85

5.06

u/ml

0.07

122

1378

Alcohol dependence

1198

0.46

8.09

1.1

5.36

3.90

u/ml

0.19

471

Vocal cord dysfunction

136

742

1.72

8.04

1.2

1.0

3.02

4.03

u/ml

0.43

274

Mental and behavioural disorders due to psychoactive substance use

264

3580

0.69

7.99

1.1

6.39

4.89

u/ml

0.63

132

1479

Organic, including symptomatic, mental disorders

703

0.40

7.96

1.0

1.1

1.85

3.23

u/ml

0.61

277

Cystitis

768

3751

1.26

7.89

1.1

5.64

5.31

u/ml

0.15

295

1582

233

3136

0.68

7.85

1.1

4.95

5.16

u/ml

0.07

114

1307

Substance abuse, excluding more controls

249

3156

0.69

7.84

1.1

6.56

4.56

u/ml

0.91

126

1293

Autoimmune diseases excluding thyroid diseases, strict definition

694

4856

0.79

7.78

1.1

5.39

5.49

u/ml

0.04

296

2124

Inflammatory diseases of prostate (prostatitis)

330

2.10

7.75

1.1

1.0

2.70

3.72

u/ml

0.27

139

Stroke, including SAH

109

1403

0.57

7.71

1.0

1.1

3.67

3.31

u/ml

0.09

528

Autoimmune diseases excluding thyroid diseases

709

4924

0.80

7.71

1.1

5.30

5.45

u/ml

0.08

302

2148

Unspecified mental disorder

197

2962

0.66

7.65

1.1

4.92

4.76

u/ml

0.04

101

1247

Disorders of synovium and tendon

445

3030

1.33

7.49

1.0

1.1

3.90

4.75

u/ml

0.50

184

1229

Parodontitis

400

3921

0.75

7.32

1.1

4.77

3.97

u/ml

0.39

174

1553

Parodontitis or operation codes

401

3923

0.75

7.28

1.1

4.74

3.97

u/ml

0.37

175

1554

Functional dyspepsia

192

1265

1.53

7.20

1.1

3.78

4.07

u/ml

0.08

495

Malignant neoplasm of breast, HER2-negative

140

1650

0.62

7.19

1.0

1.1

2.69

3.15

u/ml

0.17

589

Mental and behavioural disorders due to alcohol

205

2938

0.68

7.15

1.1

5.33

4.75

u/ml

0.20

103

1226

Polyarthropathies

350

3150

0.74

7.08

1.1

2.61

4.84

u/ml

2.95

139

1279

Chronic periodontitis, including avohilmo

400

3912

0.75

7.03

1.1

4.77

3.97

u/ml

0.39

174

1552

Cervicocranial syndrome

469

1.87

7.01

1.1

4.57

3.29

u/ml

0.20

183

Other menopausal disorders

210

804

1.51

6.94

1.1

3.15

3.31

u/ml

0.06

286

Pruritus

450

1.88

6.91

1.1

5.33

2.71

u/ml

0.41

156

Selective deficiency of immunoglobulin G [IgG] subclasses

6.72

6.83

1.1

2.59

3.16

u/ml

—

Inflammatory diseases of female pelvic organs

604

3617

1.26

6.83

1.1

4.56

5.42

u/ml

0.46

240

1468

Exposure to other specified factors

680

5157

1.24

6.75

1.1

6.32

5.13

u/ml

0.46

318

2192

Hard cardiovascular diseases

232

2132

0.70

6.74

1.1

2.11

3.63

u/ml

1.26

820

Depression

904

5165

1.21

6.68

1.1

6.69

4.88

u/ml

0.97

410

2140

Diseases of oesophagus, stomach and duodenum

901

4535

1.21

6.63

1.1

4.46

4.96

u/ml

0.24

371

1886

Renal failure

1042

0.50

6.62

1.0

1.1

7.59

3.77

u/ml

0.53

429

ILD, hospital admission 2, with pulmonary infections

139

2.61

6.61

1.1

1.96

4.71

u/ml

0.74

Depression medications

516

2016

1.29

6.61

1.1

8.10

5.55

u/ml

0.90

217

873

Insulin, intermediate and long-acting

180

2621

0.67

6.60

1.1

6.06

4.44

u/ml

0.52

1114

Lower back pain or/and sciatica

879

5053

1.21

6.59

1.1

5.95

4.75

u/ml

0.59

356

2104

Hypertrophy of breast in women and men

176

1163

1.52

6.58

1.1

6.53

3.64

u/ml

0.68

451

Metabolic disorders

476

3793

0.78

6.57

1.1

2.72

4.59

u/ml

2.77

200

1548

Trochanteric bursitis

465

1.84

6.56

1.0

1.1

1.71

2.88

u/ml

0.77

160

Lichen simplex chronicus and prurigo

177

2.40

6.46

1.1

1.0

4.54

3.69

u/ml

0.12

Acute tubulo-interstitial nephritis

258

3175

0.72

6.43

1.1

5.06

5.25

u/ml

0.05

109

1350

Benign neoplasm: Liver/bile ducts

102

2.91

6.42

1.0

1.1

5.55

6.19

u/ml

0.06

Benign neoplasm: Liver/bile ducts

102

2.91

6.42

1.0

1.1

5.55

6.78

u/ml

0.12

Vasomotor rhinitis (mode)

274

2.10

6.41

1.1

7.71

4.88

u/ml

0.22

113

Later onset COPD, excluding more controls

3.17

6.41

1.0

0.53

0.99

u/ml

—

Dysphagia

126

776

1.63

6.37

1.1

1.0

6.56

3.13

u/ml

0.94

308

Intestinal infectious diseases

843

5450

1.21

6.30

1.1

4.74

5.65

u/ml

0.82

387

2318

Cerebrovascular diseases (FINNGEN)

118

1362

0.62

6.28

1.1

5.58

3.76

u/ml

0.44

510

Other soft tissue disorders, not elsewhere classified

860

4410

1.21

6.26

1.1

5.38

5.55

u/ml

0.07

358

1902

Other anxiety disorders

536

3781

1.26

6.20

1.1

6.53

5.30

u/ml

0.58

249

1624

Chronic gastritis

110

659

1.67

6.19

1.1

1.0

8.80

3.86

u/ml

0.41

233

Acute appendicitis, no complications

527

4181

1.26

6.17

1.0

1.1

5.15

4.66

u/ml

0.22

207

1727

Allergic colitis

274

2.11

6.14

1.1

10.04

9.08

u/ml

0.10

150

Internal derangement of knee

304

2242

1.36

6.13

1.1

6.26

4.43

u/ml

0.71

123

875

Mood [affective] disorders

938

5178

1.19

6.13

1.1

6.62

4.87

u/ml

0.97

429

2149

Acute suppurative otitis media

378

2695

1.32

6.12

1.1

5.43

6.62

u/ml

0.63

186

1258

Benign neoplasm: Liver

2.94

6.10

1.0

1.1

5.92

5.66

u/ml

0.02

Enthesopathies of lower limb, excluding foot

172

1151

1.50

6.08

1.0

1.1

4.85

4.08

u/ml

0.18

438

Migraine without aura

252

1817

1.40

6.01

1.1

4.77

5.29

u/ml

0.18

107

788

Benign neoplasm: Liver

2.91

5.99

1.0

1.1

5.92

5.23

u/ml

0.06

Mood disorders

937

5179

1.19

5.96

1.1

6.62

4.87

u/ml

0.98

429

2150

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

408

1.86

5.96

1.1

4.17

4.64

u/ml

0.12

166

Stroke, excluding SAH

100

1229

0.60

5.94

1.0

3.19

3.34

u/ml

0.03

458

Dental caries 2 and operation codes, only avohilmo

694

3522

1.23

5.94

1.1

6.39

5.49

u/ml

0.49

315

1532

Injuries to the wrist and hand

895

5447

1.19

5.91

1.1

6.56

5.15

u/ml

0.89

403

2298

Disorders of eyelid, lacrimal system and orbit

600

3804

1.24

5.91

1.1

4.64

5.01

u/ml

0.18

246

1569

Otalgia

439

1.82

5.88

1.1

6.53

7.01

u/ml

0.07

199

Non-invasive ventilation

183

1174

1.47

5.82

1.0

1.1

2.49

4.95

u/ml

2.19

109

461

Ischaemic Stroke, excluding all haemorrhages

1117

0.59

5.77

1.0

2.90

3.12

u/ml

0.05

419

Restless leg syndrome

436

1.80

5.68

1.1

8.54

3.75

u/ml

0.60

173

Other diseases of urinary system

896

4236

1.19

5.67

1.1

4.97

5.33

u/ml

0.20

367

1801

Occupational exposure to risk-factors

115

2.65

5.67

1.1

0.67

3.40

u/ml

1.84

Unspecified chronic bronchitis

3.72

5.65

1.2

1.1

3.79

4.30

u/ml

—

Migraine without aura and triptan purchases

199

1396

1.44

5.59

1.1

5.15

4.65

u/ml

0.13

606

ILD-related respiratory insufficiency

4.28

5.57

1.1

1.18

4.22

u/ml

—

COPD, hospital admission 2, with asthma infections

499

1.68

5.51

1.1

1.0

7.39

2.82

u/ml

0.89

200

TMD related operations

156

1047

1.50

5.50

1.1

3.57

4.98

u/ml

0.57

412

Accidents

845

3543

1.20

5.49

1.1

1.0

6.02

5.29

u/ml

0.35

383

1460

Other viral diseases

326

2475

1.32

5.48

1.1

7.88

6.31

u/ml

0.54

154

1123

Hypertrophy of breast

158

1067

1.49

5.41

1.1

5.07

3.64

u/ml

0.41

407

Heart failure, not strict

221

2107

0.72

5.37

1.1

3.73

3.66

u/ml

0.02

832

Somatoform disorder

144

956

1.52

5.36

1.1

8.70

4.05

u/ml

0.48

376

Peritonsillar abscess

169

1163

1.46

5.26

1.1

1.0

5.37

4.74

u/ml

0.17

443

Other diseases of oesophagus

234

2.06

5.25

1.1

1.98

2.95

u/ml

0.41

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

582

4818

0.82

5.20

1.1

4.54

5.35

u/ml

0.43

245

2046

Pain in thoracic spine

121

779

1.56

5.19

1.1

8.36

4.37

u/ml

0.69

296

Coronary revascularization (ANGIO or CABG)

718

0.53

5.19

1.1

1.0

0.93

2.42

u/ml

1.92

271

Parodontitis and operation codes

387

3819

0.79

5.14

1.1

4.65

4.00

u/ml

0.30

166

1516

Diseases of appendix

646

4880

1.21

5.13

1.1

4.97

4.63

u/ml

0.17

253

2006

Appendicitis, broad definition

643

4874

1.21

5.11

1.1

4.97

4.60

u/ml

0.18

253

2003

Sub-endpoint used in defining T1D endpoints

128

1889

0.66

5.09

1.1

6.62

5.33

u/ml

0.34

844

Transport accidents

435

3070

1.26

5.09

1.1

1.0

4.63

5.09

u/ml

0.23

188

1280

Other degenerative diseases of the nervous system

723

0.52

5.07

1.0

1.94

3.05

u/ml

0.45

268

Emergency coronary revascularization (for ACS)

761

0.55

5.05

1.1

1.0

0.88

2.42

u/ml

2.33

291

GASTRO-related operations

939

4014

1.18

5.03

1.1

5.12

6.00

u/ml

0.66

397

1768

Any gastric operation

939

4014

1.18

5.03

1.1

5.12

6.00

u/ml

0.66

397

1768

Diseases of male genital organs

386

1517

1.29

5.01

1.1

4.73

5.50

u/ml

0.31

163

731

Acute and transient psychotic disorders

729

0.46

5.01

1.1

6.46

4.11

u/ml

0.35

290

Other enthesopathies

214

1552

1.38

4.98

1.1

4.17

3.50

u/ml

0.17

580

Dermatitis due to substances taken internally

233

2.04

4.97

1.1

7.12

4.71

u/ml

0.48

Condition for Implicit Sepsis (Organ dysfunction codes)

408

3723

0.79

4.94

1.1

4.88

5.04

u/ml

0.07

178

1558

Disturbances of skin sensation

243

1802

1.36

4.93

1.1

5.80

4.69

u/ml

0.30

727

Disorders of lipoprotein metabolism and other lipidaemias

300

2464

0.76

4.92

1.0

1.1

2.56

3.75

u/ml

0.95

129

938

Glucagon-like peptide-1 (GLP-1) analogues

106

1351

0.64

4.86

1.0

7.78

2.66

u/ml

0.86

509

Other neurological diseases

231

2501

0.74

4.83

1.1

3.45

4.20

u/ml

0.35

107

1003

Type 1 diabetes

128

1895

0.67

4.83

1.1

6.62

5.33

u/ml

0.35

842

Mouth breathing

285

2168

1.32

4.83

1.1

3.80

5.16

u/ml

0.77

124

915

Symptoms and signs involving the skin and subcutaneous tissue

518

4217

1.23

4.80

1.1

6.04

5.01

u/ml

0.50

212

1741

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

949

0.59

4.78

1.0

4.13

3.32

u/ml

0.22

370

Olecranon bursitis

164

2.21

4.72

1.1

6.72

3.49

u/ml

0.70

Idiopathic pulmonary fibrosis

2.80

4.71

1.0

1.1

1.36

2.99

u/ml

0.59

Drug-induced adrenocortical insufficiency

3.08

4.71

1.1

9.31

5.96

u/ml

—

Persons encountering health services for examination and investigation

630

2615

1.21

4.69

1.1

1.0

4.58

5.80

u/ml

0.77

269

1051

Allergic contact dermatitis due to drugs in contact with skin

2.89

4.68

1.0

1.1

11.23

5.64

u/ml

—

Dislocation, sprain and strain of joints and ligaments of knee

568

4367

1.21

4.66

1.1

5.90

5.04

u/ml

0.25

252

1789

Spondylolisthesis/Spondylolysis

110

713

1.55

4.62

1.0

1.1

3.54

3.52

u/ml

0.00

269

Cervicalgia

133

898

1.49

4.61

1.1

4.33

3.70

u/ml

0.19

335

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1177

0.63

4.61

1.1

1.62

3.08

u/ml

1.61

422

Acute appendicitis

608

4785

1.20

4.60

1.0

1.1

4.86

4.59

u/ml

0.13

241

1971

Examination and observation for other reasons

521

2589

1.23

4.58

1.1

1.0

3.96

5.84

u/ml

1.75

216

1035

Endometriosis of pelvic peritoneum

169

1181

1.42

4.58

1.1

2.40

4.47

u/ml

1.42

481

Non-allergic asthma

304

1.85

4.56

1.1

1.0

1.25

3.14

u/ml

0.92

113

Chondrocostal junction syndrome [Tietze]

135

2.33

4.54

1.0

1.1

5.35

7.67

u/ml

0.35

General symptoms and signs

1065

4635

1.15

4.49

1.1

6.05

5.27

u/ml

0.42

443

1982

Emphysema

2.94

4.44

1.3

1.0

1.15

2.68

u/ml

—

External causes of morbidity and mortality

716

3023

1.19

4.43

1.1

7.12

5.10

u/ml

1.04

320

1258

Ocular pain

456

1.68

4.43

1.1

2.65

4.36

u/ml

1.03

179

Benign neoplasm: Colon, unspecified

493

1.65

4.43

1.0

1.1

3.73

3.25

u/ml

0.10

186

Recurring oral aphthae, including avohilmo

104

674

1.55

4.41

1.1

2.00

6.37

u/ml

4.27

298

Other noninfective gastroenteritis and colitis

193

1408

1.38

4.38

1.1

5.96

6.24

u/ml

0.07

621

Type 1 diabetes, wide definition

117

1725

0.67

4.37

1.1

7.66

4.99

u/ml

0.77

776

Spinal osteochondrosis

3.58

4.37

1.1

31.28

2.64

u/ml

—

Other disorders of penis

421

1.70

4.32

1.1

3.74

5.50

u/ml

0.55

218

Persons encountering health services for specific procedures and health care

959

5154

1.15

4.27

1.1

5.80

5.18

u/ml

0.33

487

2128

Female infertility, cervigal, vaginal, other or unspecified origin

314

1642

1.29

4.23

1.1

6.09

5.45

u/ml

0.18

111

682

Hypothyroidism, other/unspecified

741

4169

1.18

4.22

1.1

4.76

5.15

u/ml

0.14

278

1735

Schizoaffective disorder

503

0.41

4.20

1.0

1.1

3.66

4.28

u/ml

0.12

204

Disorders of the thyroid gland

786

4402

1.17

4.18

1.1

4.75

5.18

u/ml

0.17

298

1842

Embedded and impacted teeth

377

2575

1.25

4.18

1.1

8.85

6.32

u/ml

0.75

180

1194

Type 1 diabetes, wide definition, subgroup 1

113

1660

0.68

4.16

1.1

6.33

4.93

u/ml

0.37

742

Preparation and fitting of bite rail to mouth

124

846

1.48

4.15

1.1

3.39

3.93

u/ml

0.16

333

Other external causes of accidental injury

824

3543

1.17

4.11

1.1

1.0

5.98

5.29

u/ml

0.33

379

1460

Generalized anxiety disorder

185

1360

1.37

4.08

1.1

6.80

5.36

u/ml

0.32

602

Struck by thrown, projected or falling objec

259

1.88

4.05

1.1

7.07

4.94

u/ml

0.19

109

Exclusions for E4_PCOS_CONSORTIUM

533

3999

0.83

4.05

1.0

1.1

3.39

5.52

u/ml

2.53

193

1685

Striking against or struck by other objects

298

2344

1.28

4.01

1.1

5.18

5.86

u/ml

0.28

117

1064

Continuous positive airway pressure

132

789

1.45

3.99

1.1

6.42

5.22

u/ml

0.21

324

Transplanted organ and tissue status

462

0.41

3.96

1.0

1.1

14.78

5.91

u/ml

—

201

Hypermobility syndrome

426

1.66

3.93

1.1

5.46

4.37

u/ml

0.16

169

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

264

2053

1.29

3.93

1.1

5.83

4.92

u/ml

0.34

129

868

Provisional assignment of new diseases of uncertain etiology

392

3191

1.23

3.92

1.1

5.82

5.66

u/ml

0.05

183

1384

Unspecified acute lower respiratory infection

112

758

1.49

3.92

1.1

1.0

5.23

4.84

u/ml

0.10

300

Iron deficiency

165

2.11

3.92

1.1

2.86

6.82

u/ml

0.85

Codes for special purposes

392

3193

1.23

3.90

1.1

5.82

5.66

u/ml

0.05

183

1386

Benign neoplasm: Colon, unspecified

508

1.59

3.89

1.0

1.1

3.73

3.24

u/ml

0.10

182

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

568

0.47

3.89

1.1

9.89

5.13

u/ml

0.45

242

Persons encountering health services for other counselling and medical advice, not elsewhere classified

984

4910

1.14

3.87

1.1

5.94

5.24

u/ml

0.36

447

2075

Implicit Sepsis

293

2877

0.79

3.86

1.1

5.18

4.77

u/ml

0.14

134

1188

Dislocation, sprain and strain of joints and ligaments at neck level

160

1161

1.39

3.85

1.1

7.32

5.46

u/ml

0.39

483

Hypothyreosis and Thyroxine purchase for inclusion criteria

752

4270

1.16

3.84

1.1

4.71

5.10

u/ml

0.14

281

1770

Other disorders of adrenal gland

221

1.92

3.84

1.1

5.71

5.57

u/ml

0.01

Other and unspecified rosacea

352

1.72

3.84

1.1

4.92

4.18

u/ml

0.13

124

Arthropathies

995

4434

1.14

3.83

1.1

6.02

5.58

u/ml

0.18

446

1905

Other inflammation of eyelid

545

1.57

3.83

1.0

1.1

4.14

3.92

u/ml

0.03

208

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

132

1276

0.71

3.83

1.1

3.06

u/ml

0.00

483

Acute renal failure

442

0.41

3.82

1.1

3.76

4.16

u/ml

—

178

Cervical disc disorders

197

1477

1.34

3.81

1.1

1.0

4.10

3.64

u/ml

0.12

547

COPD, hospital admissions 1, only main diagnosis

536

1.53

3.80

1.1

3.18

2.91

u/ml

0.06

205

Candidiasis

650

1.52

3.79

1.2

1.1

4.13

3.48

u/ml

0.11

270

Coronary artery bypass grafting

293

0.36

3.79

1.1

1.0

0.47

2.75

u/ml

—

109

Type 1 diabetes, strict (exclude DM2)

1059

0.62

3.79

1.1

7.93

6.09

u/ml

0.31

485

Pleural plaque

2.84

3.79

1.1

0.49

1.80

u/ml

—

COPD-related respiratory insufficiency

153

2.10

3.77

1.1

1.0

1.13

2.05

u/ml

0.66

Other and unspecified drugs and medicaments

354

1.71

3.77

1.1

4.21

4.73

u/ml

0.11

137

Nummular dermatitis

215

1.92

3.77

1.1

1.0

1.35

3.44

u/ml

1.04

L04AD Calcineurin inhibitors

614

0.50

3.74

1.0

1.1

13.31

6.07

u/ml

0.54

273

Other extrapyramidal and movement disorders in other diseases

114

782

1.46

3.74

1.1

6.16

3.61

u/ml

0.50

302

Separation of retinal layers (serosa)

141

2.15

3.72

1.1

1.0

2.65

4.81

u/ml

0.54

Substance use, excluding alcohol

1362

0.66

3.72

1.1

8.01

5.09

u/ml

0.64

559

Any dementia, excluding more controls

275

0.38

3.71

1.0

1.1

0.24

1.89

u/ml

—

104

Dementia, including avohilmo

361

0.46

3.70

1.0

1.94

1.99

u/ml

—

147

Other and unspecified vaccines and biological substances

3.38

3.68

1.2

1.1

3.25

9.53

u/ml

—

Erysipelas

163

2012

0.74

3.68

1.0

1.1

4.98

3.38

u/ml

0.57

781

Adenomyosis (Endometriosis of uterus)

567

1.54

3.66

1.1

1.43

3.81

u/ml

2.58

218

Use of disulfiram, acamprosate or naltrexone

459

0.43

3.64

1.1

2.16

3.99

u/ml

0.48

174

Atypical facial pain

197

1.95

3.64

1.1

0.29

4.00

u/ml

—

Hypertensive diseases

505

3405

0.84

3.63

1.1

3.29

4.30

u/ml

0.85

203

1355

Oesophagitis

149

2.10

3.63

1.1

3.60

4.98

u/ml

0.21

Subjective visual disturbances

162

1190

1.37

3.62

1.1

6.75

4.98

u/ml

0.43

476

COPD related to multimorbidity

543

1.51

3.61

1.1

1.0

4.30

2.11

u/ml

0.63

205

Dementia

329

0.44

3.61

1.0

1.94

1.75

u/ml

—

132

Insulin, fast-acting

153

2078

0.73

3.60

1.1

7.50

4.86

u/ml

0.74

907

Persons encountering health services in other circumstances

328

2647

1.24

3.58

1.1

5.82

5.53

u/ml

0.10

136

1157

Any dementia

274

0.39

3.57

1.0

0.24

1.68

u/ml

—

109

Hypothyroidism, strict autoimmune

641

3632

1.17

3.55

1.1

5.33

5.02

u/ml

0.10

246

1504

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

3.10

3.55

1.3

1.0

2.36

6.75

u/ml

—

Diarrhoea and gastroenteritis of presumed infectious origin

615

4783

1.17

3.55

1.1

4.73

5.63

u/ml

0.66

290

2052

Other noninflammatory disorders of vagina

376

1.66

3.54

1.0

1.1

2.85

4.08

u/ml

0.24

143

Hypertension

506

3401

0.84

3.53

1.1

3.29

4.31

u/ml

0.87

204

1351

Adrenocortical insufficiency

151

2.08

3.53

1.1

6.96

3.63

u/ml

0.30

Insulin, fast-acting or short human

153

2071

0.74

3.53

1.1

7.50

4.83

u/ml

0.75

904

Other disorders of patella

160

1179

1.36

3.52

1.1

3.63

3.92

u/ml

0.08

442

Disorders of gallbladder, biliary tract and pancreas

509

3888

0.84

3.52

1.0

1.1

3.45

4.33

u/ml

0.63

190

1554

TMD related pain

207

1.91

3.51

1.1

4.06

5.39

u/ml

0.17

Follow-up examination after treatment for conditions other than malignant neoplasms

381

2040

1.23

3.51

1.1

1.0

3.70

5.49

u/ml

1.48

152

779

Blepharochalasis

645

1.49

3.51

1.1

1.0

1.16

2.71

u/ml

1.83

224

Anomalies of dental arch relationship, including avohilmo

227

1579

1.30

3.50

1.1

8.91

6.88

u/ml

0.37

116

728

Septicaemia

106

1463

0.69

3.47

1.1

6.11

4.70

u/ml

0.31

597

Infective dermatitis

401

1.63

3.47

1.1

8.16

3.27

u/ml

0.78

127

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

570

4786

0.85

3.47

1.1

5.02

5.04

u/ml

0.00

250

1999

Lichen simplex chronicus

106

2.29

3.46

1.0

1.1

8.12

3.00

u/ml

—

Lichen planus

363

1.66

3.45

1.1

7.34

2.84

u/ml

0.62

139

Other otitis externa (chronic)

281

1.76

3.44

1.0

1.1

14.61

4.81

u/ml

0.36

122

Pure hypercholesterolaemia

235

2016

0.78

3.43

1.0

1.1

2.67

3.60

u/ml

0.59

112

775

Mood disorders, excluding more controls

821

4363

1.15

3.43

1.1

6.57

4.64

u/ml

0.95

371

1781

Other general symptoms and signs

369

1.65

3.40

1.1

8.85

7.48

u/ml

0.12

183

Peripheral artery disease

647

0.58

3.40

1.0

1.08

2.46

u/ml

1.58

247

Umbilical hernia

162

1203

1.35

3.40

1.0

1.1

2.35

3.60

u/ml

0.98

472

Visual disturbances

313

2532

1.24

3.39

1.1

6.99

5.12

u/ml

0.48

156

1070

Female infertility

343

1721

1.24

3.36

1.1

5.84

5.66

u/ml

0.05

133

724

Sulfonylureas

443

0.50

3.35

1.0

1.1

3.64

2.41

u/ml

0.32

161

Valvular heart disease excluding rheumatic fever

124

1262

0.72

3.35

1.1

3.07

5.04

u/ml

1.11

513

Finngen Rheumatological endpoints

724

4745

0.87

3.34

1.1

3.21

5.35

u/ml

3.90

301

1976

Type 1 diabetes, definitions combined

1061

0.64

3.33

1.1

8.96

5.98

u/ml

0.52

485

Diaphragmatic hernia

151

1114

1.36

3.31

1.1

1.49

2.78

u/ml

1.66

418

Diseases of external ear

218

1696

1.29

3.30

1.1

7.77

5.63

u/ml

0.36

103

710

Acute laryngitis and tracheitis

157

1150

1.35

3.28

1.1

5.24

7.14

u/ml

0.73

527

Bacterial Sepsis

103

1308

0.70

3.28

1.0

1.1

3.91

4.08

u/ml

0.05

522

Other disorders of cornea

347

1.65

3.23

1.1

10.08

3.87

u/ml

1.25

137

Disorders of skin appendages

419

3507

1.20

3.22

1.1

5.03

5.73

u/ml

0.36

185

1530

Disorders of sclera, cornea, iris and ciliary body

388

3227

1.21

3.21

1.1

5.80

4.85

u/ml

0.52

186

1339

Nephropathy related operations

449

0.47

3.20

1.0

1.1

5.58

4.84

u/ml

—

194

Type 1 diabetes, strict definition, subgroup 1

917

0.63

3.20

1.1

7.58

5.98

u/ml

0.24

425

Dialysis, with operation codes

462

0.47

3.19

1.0

1.1

4.88

4.79

u/ml

0.01

205

Mycoses

167

1259

1.33

3.19

1.1

4.66

3.91

u/ml

0.17

520

Visual disturbances and blindness

326

2667

1.23

3.19

1.1

6.80

5.09

u/ml

0.45

162

1136

Subacute thyroiditis

144

2.04

3.17

1.0

0.91

6.50

u/ml

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

460

0.58

3.16

1.0

1.1

0.97

2.51

u/ml

0.89

183

Peroneal tendinitis

2.58

3.15

1.0

1.1

1.32

4.45

u/ml

—

Ganglion

172

1306

1.32

3.14

1.0

1.1

3.54

5.03

u/ml

0.76

514

Short Achilles tendon (acquired)

2.27

3.14

1.0

1.1

1.38

2.67

u/ml

0.66

Non-rheumatic valve diseases

121

1220

0.72

3.13

1.1

2.91

4.81

u/ml

1.03

487

Keratitis

250

1992

1.26

3.13

1.1

6.70

4.73

u/ml

1.04

122

816

Other and unspecified disorders of vitreous body

145

1068

1.35

3.12

1.0

2.52

3.10

u/ml

0.20

377

Covid-19 confirmed case

205

1596

1.29

3.11

1.1

6.39

5.36

u/ml

0.26

681

Pre-eclampsia or poor fetal growth

222

2797

0.79

3.11

1.1

4.08

4.94

u/ml

0.33

1123

Other disorders of eye and adnexa

112

797

1.41

3.10

1.1

4.09

4.18

u/ml

0.03

323

Reimbursement for rheumatic diseases

270

3329

0.81

3.08

1.0

1.1

3.14

4.73

u/ml

1.18

112

1375

Faecal incontinence

209

1.83

3.08

1.1

1.0

1.06

3.54

u/ml

—

Injuries to the ankle and foot

670

5324

1.15

3.06

1.1

5.57

u/ml

0.00

311

2267

Otitis externa

164

1242

1.33

3.06

1.1

7.47

5.15

u/ml

0.28

518

Other disorders of eyelid

155

1123

1.34

3.06

1.1

3.85

3.13

u/ml

0.17

407

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

475

2614

1.18

3.06

1.1

4.25

5.92

u/ml

1.14

210

1078

Other intervertebral disc disorders

627

3320

1.16

3.05

1.0

1.1

5.27

4.04

u/ml

0.48

260

1330

Heart failure,strict

913

0.69

3.05

1.1

1.0

3.84

3.52

u/ml

0.04

367

Unspecific neurodegenerative disorder

239

0.40

3.05

1.1

1.0

3.29

1.43

u/ml

—

Appendectomy

569

4729

1.16

3.05

1.0

1.1

4.06

4.77

u/ml

0.47

234

1939

Gluteal tendinitis

126

2.08

3.03

1.0

1.1

2.53

2.21

u/ml

0.06

Type 1 diabetes, strict definition

965

0.65

3.03

1.1

9.76

6.18

u/ml

0.61

450

Coronary angioplasty

578

0.60

3.03

1.0

0.95

2.62

u/ml

1.92

223

Rosacea

537

1.50

3.01

1.1

5.78

3.56

u/ml

0.62

198

Deep bite

135

870

1.37

3.01

1.1

12.71

8.32

u/ml

0.52

445

Bruxism

107

2.19

2.99

1.1

2.00

2.94

u/ml

—

Dislocation, sprain and strain of joint and ligaments of hip

2.37

2.99

1.1

5.81

4.79

u/ml

—

Other viral hepatitis

449

0.49

2.99

1.2

1.1

9.38

4.24

u/ml

0.42

183

Monoplegia

3.05

2.99

1.0

1.1

0.32

1.52

u/ml

—

Herpesviral [herpes simplex] infections

587

1.47

2.99

1.1

10.02

4.11

u/ml

1.22

232

Malaise and fatigue

303

2063

1.23

2.97

1.1

4.80

4.89

u/ml

0.03

138

880

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

249

1.74

2.97

1.0

1.1

1.95

4.18

u/ml

0.82

102

Excessive attrition of teeth

385

1738

1.21

2.97

1.0

1.1

4.27

5.96

u/ml

1.07

175

731

Bleeding

344

3014

0.83

2.96

1.1

4.75

4.86

u/ml

0.04

154

1239

Other congenital malformations of skin

257

1.73

2.96

1.1

7.62

6.55

u/ml

0.17

125

Heart failure, strict

922

0.69

2.95

1.1

1.0

3.73

3.40

u/ml

0.04

366

Benign neoplasm: Scapula and long bones of upper limb

3.21

2.95

1.0

1.1

1.42

4.55

u/ml

—

Diagnoses used for exclusion with ILD

120

872

1.38

2.94

1.1

3.05

3.72

u/ml

0.22

340

Heart failure and antihypertensive medication

616

0.64

2.93

1.1

1.0

4.92

3.90

u/ml

0.11

238

Prurigo nodularis

2.85

2.93

1.0

0.22

1.30

u/ml

—

Exophthalmic conditions

3.40

2.92

1.0

1.14

9.33

u/ml

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

498

3479

1.17

2.92

1.0

1.1

3.95

4.68

u/ml

0.43

186

1389

malignant neoplasm of male genital organs

466

0.60

2.89

1.0

0.57

2.60

u/ml

2.38

180

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

390

0.46

2.88

1.0

1.1

—

3.14

u/ml

—

148

Major coronary heart disease event

162

1412

0.76

2.87

1.1

1.0

1.33

2.89

u/ml

2.66

543

Viral pneumonia

592

1.46

2.87

1.1

9.96

4.33

u/ml

0.91

253

Oedema, not elsewhere classified

165

1259

1.31

2.83

1.1

2.69

3.92

u/ml

0.95

513

Tinnitus

128

947

1.36

2.82

1.1

6.47

3.26

u/ml

0.65

365

Statin medication

488

3192

0.86

2.82

1.1

3.28

4.06

u/ml

0.50

183

1302

Patellar tendinitis

2.20

2.79

1.0

1.1

18.52

6.80

u/ml

0.58

Single spontaneous delivery

243

1607

0.80

2.79

1.1

4.79

6.67

u/ml

0.85

119

704

Urticaria due to cold and heat

2.93

2.78

1.1

1.0

9.90

6.86

u/ml

—

Other obstetric conditions, not elsewhere classified

477

2653

1.17

2.77

1.1

4.38

5.86

u/ml

0.95

207

1090

Other disorders of bone

160

1228

1.31

2.76

1.0

1.1

5.59

5.09

u/ml

0.10

493

Injury, poisoning and certain other consequences of external causes

586

2544

1.16

2.76

1.1

5.91

5.18

u/ml

0.35

268

1059

Nonsuppurative otitis media

287

2036

1.22

2.76

1.1

5.55

7.64

u/ml

1.11

141

974

Benign neoplasm of other and ill-defined parts of digestive system

515

1.48

2.75

1.1

4.78

3.39

u/ml

0.34

194

Other contact dermatitis

363

1.58

2.75

1.1

10.22

3.27

u/ml

1.29

120

Disorders of muscles

443

1.52

2.74

1.1

3.71

4.56

u/ml

0.21

170

Foreign body in alimentary tract

218

1.76

2.73

1.1

3.65

4.99

u/ml

0.29

102

Other benign neoplasms of uterus

2.37

2.72

1.1

5.73

1.72

u/ml

—

Other septicaemia

1265

0.71

2.72

1.1

6.68

4.43

u/ml

0.48

529

ILD, hospital admissions 3, with pneumonia sepsis

118

2.04

2.71

1.1

0.74

3.21

u/ml

1.18

Combinations of oral blood glucose lowering drugs

800

0.64

2.70

1.0

1.39

2.99

u/ml

1.79

288

Hypothyroidism, strict autoimmune, 3 medication purchases required

670

4015

1.14

2.70

1.1

5.14

5.03

u/ml

0.03

255

1654

Inflammatory disease of uterus

141

1068

1.33

2.69

1.1

3.61

5.04

u/ml

0.38

437

Vulvovaginal ulceration/inflammation in other diseases

455

1.51

2.66

1.1

1.0

3.38

3.94

u/ml

0.19

173

Lumbar disc prolapse

445

3026

1.17

2.65

1.1

4.61

3.75

u/ml

0.40

197

1213

Other spirochaetal diseases

141

1070

1.32

2.65

1.1

3.61

3.70

u/ml

0.02

424

Lichen planus, including avohilmo

586

1.44

2.64

1.0

1.1

5.99

3.37

u/ml

0.40

210

Genitourinary diseases

633

2775

1.15

2.63

1.1

6.05

6.18

u/ml

0.05

273

1300

Viral hepatitis

480

0.54

2.62

1.2

1.1

9.38

4.18

u/ml

0.43

194

Rotator cuff syndrome

341

2120

1.20

2.61

1.0

1.1

1.78

3.69

u/ml

3.54

135

788

Atrial fibrillation and flutter

130

1125

0.75

2.61

1.0

1.80

3.78

u/ml

2.30

419

Noninfective enteritis and colitis

361

3045

1.19

2.61

1.1

6.55

5.59

u/ml

0.37

160

1336

Chondropathies

125

935

1.34

2.61

1.0

1.1

6.31

4.70

u/ml

0.33

380

Other disorders of urethra and urinary system

515

3343

1.16

2.60

1.1

5.81

4.92

u/ml

0.39

204

1387

Impacted teeth

269

2059

1.22

2.60

1.1

9.39

7.12

u/ml

0.67

129

960

Polyarteritis nodosa and related conditions

2.94

2.59

1.1

0.66

2.97

u/ml

—

Panic disorder

170

1329

1.29

2.59

1.1

3.89

5.28

u/ml

0.61

570

Lichen ruber planus, wide definition including periferal and oral lichen planus

714

1.39

2.59

1.1

1.0

5.39

3.40

u/ml

0.34

255

Mental retardation, wide definition

371

0.48

2.58

1.2

1.1

6.22

8.24

u/ml

—

201

Deforming dorsopathies

194

1541

1.26

2.58

1.0

1.1

6.75

5.43

u/ml

0.18

635

Other abnormal products of conception

403

2284

1.18

2.56

1.1

4.74

4.90

u/ml

0.06

155

893

Disorders of breast

383

3016

1.18

2.56

1.1

5.54

4.56

u/ml

0.41

141

1201

Disorders of choroid and retina

295

2583

0.83

2.56

1.1

3.68

3.82

u/ml

0.05

120

1026

Asymmetry of jaw

108

2.08

2.55

1.1

4.13

7.02

u/ml

0.44

Otitis media, unspecified

148

1048

1.31

2.54

1.2

1.1

10.72

8.65

u/ml

0.25

521

Endometriosis ASRM stages 1,2

171

1342

1.28

2.53

1.1

2.36

4.35

u/ml

1.61

533

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

273

0.40

2.53

1.2

1.1

3.56

4.10

u/ml

—

119

Chronic viral hepatitis

395

0.50

2.52

1.1

9.38

4.39

u/ml

0.40

164

Diseases of salivary glands

125

940

1.33

2.52

1.1

3.38

5.90

u/ml

0.90

350

Retinal breaks without detachment

453

1.48

2.49

1.1

1.79

2.35

u/ml

0.28

171

All-cause Heart Failure

891

0.72

2.47

1.1

1.0

3.73

3.45

u/ml

0.04

356

Mental and behavioural disorders due to cannabinoids

269

0.40

2.47

1.1

17.63

5.78

u/ml

—

119

Lateral epicondylitis

662

1.40

2.46

1.1

3.17

3.38

u/ml

0.06

237

Seborrhoeic dermatitis

318

1.58

2.46

1.1

1.0

2.79

3.13

u/ml

0.09

113

Persons with potential health hazards related to communicable diseases

442

3789

1.16

2.43

1.1

6.84

6.07

u/ml

0.31

209

1708

Kidney transplant status

253

0.39

2.42

1.0

1.1

23.63

6.85

u/ml

—

117

Chronic conjunctivitis

131

1.93

2.42

1.0

1.1

6.78

5.30

u/ml

0.15

Correction of physiology of bite - demanding therapy visit

441

1.49

2.41

1.1

5.44

4.07

u/ml

0.29

177

Hernia of abdominal wall

239

1959

1.22

2.40

1.0

1.1

3.17

3.88

u/ml

0.39

102

779

Fibromyalgia

515

1.45

2.40

1.1

4.21

3.29

u/ml

0.21

190

Other localized connective tissue disorders

0.00

2.40

0.0

1.1

—

4.48

—

Fracture of femur

473

0.58

2.39

1.0

1.1

2.81

4.30

u/ml

—

201

All influenza (not pneumonia)

116

872

1.34

2.37

1.1

1.21

5.02

u/ml

6.46

374

Inflammation of lacrimal passages (acute and unspecified)

2.64

2.37

1.2

1.0

0.23

5.57

u/ml

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

161

1.82

2.36

1.1

11.03

6.74

u/ml

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

176

1.78

2.36

1.0

1.1

5.54

4.40

u/ml

0.15

Rheumatism, unspecified

550

1.42

2.35

1.1

1.0

1.32

3.15

u/ml

1.58

190

Insulin, fast-acting (human)

1055

0.71

2.34

1.1

6.37

4.62

u/ml

0.38

446

Mental retardation

357

0.50

2.34

1.2

1.1

6.22

8.26

u/ml

—

194

Menorrhagia

297

1369

1.20

2.34

1.1

3.47

4.66

u/ml

0.54

117

552

Correction of physiology of bite - very demanding therapy visit

155

1.83

2.31

1.1

1.52

4.54

u/ml

1.36

Certain infectious and parasitic diseases

960

4349

1.11

2.30

1.1

4.70

5.41

u/ml

0.55

415

1842

Pain in limb

631

4047

1.13

2.29

1.1

4.77

5.33

u/ml

0.30

262

1721

Sequelae of cerebrovascular disease

622

0.65

2.28

1.0

1.1

3.25

2.52

u/ml

0.14

237

Certain disorders involving the immune mechanism

121

921

1.32

2.28

1.1

3.07

4.30

u/ml

0.45

367

Other deformities of toe(s)

2.08

2.27

1.1

0.66

5.26

u/ml

—

Stenosis and insufficiency of lacrimal passages

301

1.57

2.27

1.1

5.15

3.77

u/ml

0.22

125

Atherosclerosis, excluding cerebral and coronary sclerosis

498

0.62

2.27

1.1

1.23

2.59

u/ml

1.08

196

Explicit Sepsis

144

1759

0.78

2.26

1.1

5.70

5.20

u/ml

0.11

743

Diseases of arteries, arterioles and capillaries

173

1614

0.80

2.26

1.0

1.1

3.06

3.03

u/ml

0.01

623

Fissure and fistula of anal and rectal regions

150

1177

1.28

2.25

1.1

4.86

3.83

u/ml

0.22

470

Disorders of refraction and accommodation

247

2043

1.21

2.22

1.1

7.86

6.84

u/ml

0.15

102

918

Hyperkinetic disorders, excluding more controls

154

1184

1.27

2.22

1.1

12.28

6.64

u/ml

0.80

572

Lyme disease

135

1048

1.29

2.21

1.1

3.68

u/ml

0.00

412

Other acute skin changes due to ultraviolet radiation

100

2.02

2.21

1.1

1.0

1.19

4.71

u/ml

1.22

Persons encountering health services in other circumstances, wide

1043

4929

1.10

2.21

1.1

5.57

5.22

u/ml

0.18

476

2086

Convergence insufficiency and excess

2.16

2.21

1.2

1.1

4.56

6.88

u/ml

—

Other diseases of stomach and duodenum

150

1.81

2.20

1.1

1.0

5.91

3.49

u/ml

0.20

Second line medication for Crohn's disease

313

3675

0.85

2.19

1.0

1.1

3.66

5.00

u/ml

0.95

127

1569

Benign neoplasm of eye and adnexa

296

1.56

2.19

1.0

1.1

1.45

4.67

u/ml

2.17

116

Other nutritional deficiencies

530

4570

1.14

2.19

1.1

5.97

4.89

u/ml

0.35

224

1865

Dental operations, only avohilmo

471

2099

1.15

2.18

1.0

1.1

4.22

4.92

u/ml

0.31

192

841

Benign neoplasm of other and ill-defined parts of digestive system

542

1.41

2.18

1.1

4.78

4.25

u/ml

0.10

202

Benign neoplasm: Choroid

136

1.85

2.18

1.0

0.41

4.02

u/ml

1.81

Hypoplasia of dental enamel, prenatal

0.00

2.17

0.0

1.2

—

7.98

—

All influenza

164

1308

1.26

2.16

1.1

1.96

5.24

u/ml

2.89

561

Gonarthrosis [arthrosis of knee](FG)

341

2349

0.85

2.16

1.1

2.71

3.62

u/ml

0.75

144

858

Other respiratory disorders and diseases

451

1.44

2.16

1.1

1.89

4.25

u/ml

1.78

189

Other diseases of the respiratory system

451

1.44

2.16

1.1

1.89

4.25

u/ml

1.78

189

Benign neoplasm of eye and adnexa

297

1.56

2.16

1.0

1.1

1.45

4.57

u/ml

2.13

119

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

689

3860

1.12

2.16

1.1

1.0

4.75

5.04

u/ml

0.15

339

1567

689

3860

1.12

2.16

1.1

1.0

4.75

5.04

u/ml

0.15

339

1567

Leiomyoma of uterus

310

2059

0.85

2.16

1.0

1.1

3.95

3.68

u/ml

0.09

105

787

Sarcoidosis

535

1.41

2.15

1.1

4.12

3.36

u/ml

0.14

199

Other disorders of white blood cells

181

1.72

2.15

1.2

1.1

1.26

5.19

u/ml

—

Malignant neoplasm of breast, HER-positive

1206

0.74

2.15

1.1

1.62

3.05

u/ml

1.57

433

Implicit bacterial Sepsis

985

0.72

2.15

1.0

1.1

3.49

3.58

u/ml

0.02

376

Other/unspecified synovitis and tenosynovitis

527

1.41

2.15

1.0

1.1

7.13

4.01

u/ml

0.38

203

Chronic kidney disease

657

0.65

2.14

1.0

1.1

8.51

4.29

u/ml

0.47

281

Flat foot [pes planus] (acquired)

387

1.48

2.13

1.1

1.0

1.48

4.20

u/ml

2.11

134

Diseases of oral cavity, salivary glands and jaws

751

3459

1.12

2.12

1.1

4.67

5.75

u/ml

0.71

339

1434

Intermittent heterotropia

534

0.61

2.11

1.1

25.32

7.13

u/ml

0.47

274

Factors influencing health status and contact with health services

271

1134

1.20

2.11

1.1

1.0

5.03

5.69

u/ml

0.24

120

427

Benign neoplasm: Scapula and long bones of upper limb

2.61

2.11

1.0

1.1

1.42

6.78

u/ml

—

Metatarsalgia

429

1.45

2.11

1.1

4.14

3.17

u/ml

0.15

158

LeFortI or BSSRO operation

284

1.56

2.10

1.1

1.63

5.28

u/ml

2.51

115

Coronary atherosclerosis

174

1391

0.81

2.10

1.1

1.0

2.26

2.96

u/ml

0.46

535

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

409

0.56

2.09

1.1

1.31

4.13

u/ml

—

157

Injuries to the neck

192

1566

1.23

2.09

1.1

8.38

5.53

u/ml

0.69

663

Crossbite

665

1.35

2.09

1.1

7.01

7.88

u/ml

0.15

351

Postmenopausal atrophic vaginitis

115

525

1.32

2.09

1.0

1.1

3.61

2.99

u/ml

0.17

185

Other viral diseases, not elsewhere classified

177

1428

1.24

2.09

1.1

11.31

6.30

u/ml

1.24

643

Other specified/unspecified bacterial intestinal infections

198

1.68

2.09

1.1

4.41

4.32

u/ml

0.01

Inflammatory disorders of breast

439

1.45

2.08

1.1

5.93

3.57

u/ml

0.67

175

Redundant prepuce, phimosis and paraphimosis

139

1088

1.28

2.08

1.0

7.37

5.59

u/ml

0.36

518

Endometriosis

320

1619

1.18

2.08

1.1

2.44

5.61

u/ml

3.95

134

674

Excessive, frequent and irregular menstruation

404

1945

1.16

2.08

1.1

3.60

6.28

u/ml

2.39

171

846

Transient ischemic attack

102

1113

0.76

2.07

1.1

1.0

2.14

2.90

u/ml

0.47

409

Rheumatoid arthritis

112

1321

0.77

2.06

1.1

2.08

3.70

u/ml

1.00

470

Other symptoms and signs involving the circulatory and respiratory systems

222

1.63

2.05

1.1

1.0

3.46

5.37

u/ml

0.30

Bacterial infection, other or unspecified

164

1834

0.81

2.05

1.1

4.29

4.15

u/ml

0.03

748

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

810

0.70

2.05

1.0

1.1

4.16

2.75

u/ml

0.25

296

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

366

0.64

2.05

1.0

1.1

0.16

2.63

u/ml

—

138

Hallux rigidus

366

1.48

2.04

1.1

1.0

2.97

2.96

u/ml

0.00

117

L02BG Aromatase inhibitors

924

0.71

2.04

1.1

1.94

3.60

u/ml

1.15

331

Perforation of tympanic membrane

474

1.42

2.04

1.0

1.1

6.34

6.78

u/ml

0.06

197

Other demyelinating diseases of the central nervous system

260

0.46

2.03

1.1

4.17

4.67

u/ml

—

Ovarian cyst

355

1764

1.17

2.03

1.1

4.75

5.71

u/ml

0.41

152

745

Other disorders starting during childhood or adolecense, excluding more controls

606

1.37

2.02

1.1

10.27

8.41

u/ml

0.24

320

Rheumatoid arthritis, including avohilmo

125

1593

0.78

2.01

1.1

2.20

3.42

u/ml

0.79

613

Thyroiditis, ILD-related definition

697

1.34

2.00

1.1

11.08

3.89

u/ml

0.33

269

Other enthesopathy of foot (+metatarsalgia)

476

1.41

2.00

1.1

3.99

3.14

u/ml

0.13

176

Complications associated with artificial fertilization

156

1.76

1.99

1.0

1.1

9.38

3.59

u/ml

0.75

Injury of muscle and tendon at hip and thigh level

402

1.45

1.98

1.1

4.24

4.79

u/ml

0.07

158

Injury of muscle and tendon at shoulder and upper arm level

147

1172

1.26

1.98

1.1

1.0

3.55

3.48

u/ml

0.02

426

Noninfectious colitis NAS

716

1.33

1.97

1.1

3.70

4.65

u/ml

0.33

307

575

1.36

1.97

1.0

2.51

2.49

u/ml

0.00

219

Complications predominantly related to the puerperium

248

2088

1.19

1.97

1.1

3.53

4.85

u/ml

0.51

850

Thyroiditis

355

1.47

1.93

1.0

1.1

19.42

4.74

u/ml

0.35

137

Pre-eclampsia or eclampsia

129

1626

0.79

1.92

1.1

3.82

4.19

u/ml

0.09

653

Mixed conductive and sensorineural hearing loss

306

1.51

1.92

1.0

1.1

1.90

2.93

u/ml

0.62

128

Contact with and exposure to communicable diseases

389

3387

1.15

1.92

1.1

7.34

6.16

u/ml

0.46

177

1536

Any operation in hilmo

206

1.47

1.92

1.1

1.0

5.51

6.22

u/ml

0.09

Fever of other and unknown origin

395

3202

1.15

1.91

1.1

5.74

5.30

u/ml

0.16

177

1406

Hypertensive diseases (excluding secondary)

430

2844

0.88

1.90

1.1

3.48

4.47

u/ml

0.68

174

1157

Other benign neoplasms of uterus

2.01

1.90

1.1

5.73

2.80

u/ml

—

Other heart diseases

395

2982

0.87

1.90

1.1

4.17

5.57

u/ml

0.81

169

1262

Disorders of ocular muscles, binocular movement, accommodation and refraction

414

3606

1.14

1.89

1.1

6.56

5.92

u/ml

0.16

188

1592

Injury of muscle and tendon at lower leg level

643

1.34

1.89

1.0

1.1

2.56

4.42

u/ml

1.07

258

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

109

964

0.77

1.89

1.1

1.0

3.42

2.75

u/ml

0.20

363

Anaemia in chronic diseases classified elsewhere

0.00

1.89

0.0

1.1

—

5.19

—

Benign intracranial hypertension

2.13

1.89

1.1

4.99

6.29

u/ml

—

L02BX Other hormone antagonists and related agents

0.00

1.88

0.0

1.1

—

2.28

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

469

3259

1.13

1.88

1.0

1.1

3.95

4.73

u/ml

0.46

177

1298

Hypothyroidism, levothyroxine purchases

367

1831

1.16

1.88

1.1

6.45

5.46

u/ml

0.22

143

791

Hypothyroidism and >3 levothyroxin purchases

367

1831

1.16

1.88

1.1

6.45

5.46

u/ml

0.22

143

791

Atrial fibrillation and flutter with reimbursement

631

0.73

1.88

1.1

1.0

0.61

3.43

u/ml

4.40

237

Other retinal disorders

192

1864

0.83

1.88

1.1

3.59

3.70

u/ml

0.03

754

Other complications of surgical and medical care, not elsewhere classified

440

1.42

1.88

1.1

2.20

4.28

u/ml

1.03

168

Carpal tunnel syndrome

366

2877

1.15

1.87

1.1

2.58

3.65

u/ml

1.08

135

1117

Dental operations

442

1991

1.14

1.86

1.0

1.1

4.40

5.00

u/ml

0.24

180

797

Benign neoplasm of bone and articular cartilage

441

1.41

1.86

1.0

1.1

2.12

5.44

u/ml

2.29

177

Atrial septal defect

314

0.53

1.86

1.1

5.42

9.17

u/ml

—

169

Persons encountering health services in circumstances related to reproduction

574

3481

1.12

1.86

1.1

5.51

6.11

u/ml

0.29

247

1547

Maternal care for other known or suspected fetal problems

252

1906

0.84

1.86

1.1

6.03

5.80

u/ml

0.05

789

Extrapyramidal and movement disorders

149

1200

1.24

1.86

1.1

1.0

5.19

3.50

u/ml

0.38

462

Infections with a predominantly sexual mode of transmission

326

2821

1.16

1.85

1.1

4.45

5.36

u/ml

0.41

130

1202

Symptoms and signs involving cognition, perception, emotional state and behaviour

588

4588

0.90

1.85

1.1

4.28

5.03

u/ml

0.51

268

1894

Seropositive rheumatoid arthritis

984

0.74

1.84

1.1

1.24

3.34

u/ml

2.83

362

Viral pneumonia (unknown virus, not influenza)

326

1.48

1.84

1.1

14.21

4.87

u/ml

0.95

136

Mental retardation, excluding more controls

322

0.54

1.84

1.2

1.1

6.22

9.63

u/ml

—

175

Measles

2.16

1.84

1.1

1.0

9.90

3.65

u/ml

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

344

1.36

1.84

1.1

2.16

3.09

u/ml

0.49

160

Delivery

262

1631

0.85

1.83

1.1

5.47

6.65

u/ml

0.41

124

721

Other appendicitis

401

1.43

1.82

1.1

4.52

4.05

u/ml

0.06

155

Other and unspecified corneal deformities and disorders

130

1.78

1.82

1.0

1.1

8.08

4.37

u/ml

0.48

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

108

1.86

1.82

1.1

4.56

5.43

u/ml

—

Ischemic heart diseases

269

1973

0.85

1.80

1.0

1.1

1.86

3.54

u/ml

2.36

755

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

948

0.74

1.80

1.1

1.27

3.51

u/ml

2.87

350

Special screening examination for neoplasms

1.92

1.80

1.1

1.0

0.12

1.30

u/ml

—

Demyelinating diseases of the central nervous system

596

0.67

1.79

1.1

2.49

3.26

u/ml

0.22

240

Cholelithiasis, broad definition with cholecystitis

438

3393

0.88

1.79

1.1

3.28

3.90

u/ml

0.39

158

1327

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

153

1.71

1.79

1.0

1.1

13.21

4.40

u/ml

—

Gingivitis and periodontal diseases

723

3381

1.11

1.79

1.1

3.81

5.47

u/ml

1.49

333

1377

Noninflammatory disorders of female genital tract

464

2063

1.13

1.78

1.1

6.12

6.46

u/ml

0.10

182

913

Malignant neoplasm of prostate

387

0.67

1.78

1.0

0.61

2.77

u/ml

2.10

148

L04AX Other immunosuppressants

303

3499

0.86

1.78

1.0

1.1

3.71

5.02

u/ml

0.90

125

1495

Major coronary heart disease event excluding revascularizations

141

1207

0.81

1.78

1.0

1.28

2.77

u/ml

2.26

449

Benign neoplasm: Choroid

146

1.72

1.77

1.0

1.1

0.41

3.77

u/ml

1.97

Pre-eclampsia

124

1552

0.80

1.77

1.0

1.1

4.09

4.23

u/ml

0.03

627

Suppurative otitis media, unspecified

154

1.71

1.77

1.0

1.1

13.93

7.23

u/ml

0.34

Nonalcoholic fatty liver disease

412

1.41

1.77

1.0

1.1

1.48

4.58

u/ml

2.17

161

Other/unspecified seropositive rheumatoid arthritis

956

0.74

1.76

1.1

1.27

3.49

u/ml

2.84

353

Pedestrian injured in collision with pedal cycle

124

1.79

1.76

1.0

1.1

2.98

5.03

u/ml

0.57

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

291

2284

1.16

1.76

1.1

10.31

6.98

u/ml

0.76

131

1116

Haemorrhage in early pregnancy

266

2223

1.17

1.76

1.1

1.0

3.50

4.90

u/ml

1.03

104

885

Ischaemic heart disease, wide definition

257

1885

0.85

1.75

1.0

1.1

1.87

3.36

u/ml

1.90

718

Seropositive rheumatoid arthritis, strict definition

569

0.67

1.74

1.1

0.56

3.52

u/ml

5.11

206

Cellulitis

140

1130

1.24

1.74

1.1

8.50

4.57

u/ml

0.99

470

Hyperplasia of prostate

114

507

1.28

1.73

1.0

1.06

2.93

u/ml

2.22

195

Examination and encounter for administrative purposes

110

1.83

1.73

1.2

1.0

9.82

2.93

u/ml

—

Deep bite that required surgery

2.16

1.73

1.0

1.1

2.62

4.84

u/ml

—

Hypothyroidism (congenital or acquired)

368

1848

1.15

1.73

1.1

6.40

5.48

u/ml

0.20

146

800

Acute pancreatitis

686

0.70

1.73

1.1

2.50

4.18

u/ml

0.93

264

Other and unspecified polyneuropathies, also in other diseases

431

1.40

1.71

1.1

4.02

3.38

u/ml

0.09

169

Acute pancreatitis (for exclusion)

685

0.70

1.71

1.1

2.50

4.14

u/ml

0.89

265

Abnormal findings on diagnostic imaging of central nervous system

210

1.58

1.71

1.0

1.1

1.86

5.73

u/ml

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

258

0.55

1.71

1.1

0.82

2.41

u/ml

—

102

Suicide or other Intentional self-harm

147

1798

0.82

1.70

1.1

6.08

5.47

u/ml

0.14

757

Viral conjunctivitis

111

1.82

1.70

1.1

7.36

6.00

u/ml

—

Vascular disorders of the intestines

2.00

1.69

1.1

0.06

2.95

u/ml

—

Unspecified event, undetermined intent

126

1.76

1.69

1.0

1.1

5.98

6.35

u/ml

0.04

Benign neoplasm: Skin of eyelid, including canthus

441

1.39

1.69

1.1

9.55

3.77

u/ml

0.59

167

Other/unspecified soft tissue disorders related to use, overuse and pressure

126

1.76

1.68

1.1

1.0

3.27

4.51

u/ml

—

Superficial injury of lower leg

187

1561

1.20

1.68

1.1

7.72

5.56

u/ml

0.30

671

Cholelithiasis

420

3321

0.89

1.68

1.0

1.1

3.34

3.70

u/ml

0.20

154

1302

Type1 diabetes, definitions combined, early onset

816

0.73

1.68

1.1

6.76

6.45

u/ml

0.05

385

Other/unspecified enthesopathies, not elsewhere classified

292

1.48

1.67

1.2

1.0

6.76

3.97

u/ml

0.19

109

Oxycodone

992

0.76

1.66

1.1

1.0

6.03

3.27

u/ml

0.38

392

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

341

0.61

1.66

1.1

0.52

2.57

u/ml

—

132

Other symptoms and signs involving the digestive system and abdomen

728

1.29

1.66

1.1

1.0

2.48

4.28

u/ml

0.94

297

Seropositive rheumatoid arthritis, wide

968

0.75

1.65

1.1

1.24

3.49

u/ml

3.01

356

Immunodeficiency with predominantly antibody defects

127

1.75

1.65

1.1

1.61

6.21

u/ml

1.70

Other erythematous conditions

112

1.80

1.65

1.1

2.71

5.64

u/ml

—

Chronic suppurative otitis media, including avohilmo

427

1.39

1.64

1.1

4.52

6.02

u/ml

0.36

192

Biological medication for rheuma

1146

0.77

1.64

1.0

1.1

2.95

5.85

u/ml

1.37

471

Panniculitis affecting regions of neck and back

150

1.68

1.64

1.1

2.10

2.91

u/ml

—

Disorders of vitreous body

177

1442

1.20

1.63

1.0

1.1

2.45

3.40

u/ml

0.47

527

Uterine polyps

394

1.40

1.62

1.0

1.1

2.52

3.49

u/ml

0.27

150

Irregular menses

487

3541

1.12

1.62

1.1

3.63

5.48

u/ml

1.59

193

1437

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

3.61

1.62

1.0

1.1

—

2.46

—

Endometriosis of rectovaginal septum and vagina

369

1.42

1.62

1.1

1.07

3.44

u/ml

2.74

145

Oral lichen ruber planus

2.16

1.61

1.0

1.1

7.99

3.37

u/ml

—

Autoimmune diseases

901

4991

0.92

1.61

1.1

5.69

5.51

u/ml

0.07

380

2178

Foreign body in respiratory tract

254

1.51

1.61

1.1

4.72

5.28

u/ml

0.08

117

Postpartum care and examination

159

1226

0.82

1.60

1.1

5.19

7.11

u/ml

0.60

512

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

560

0.68

1.60

1.0

1.1

1.86

3.32

u/ml

0.94

206

Other disorders of breast

697

1.30

1.60

1.0

1.1

4.96

3.38

u/ml

0.32

270

Benign neoplasm of bone and articular cartilage

455

1.37

1.59

1.0

1.1

2.12

5.28

u/ml

2.21

185

Foreign body entering into or through eye or natural orifice

438

1.38

1.59

1.1

3.84

5.00

u/ml

0.38

190

Other/unspecified dorsalgia

238

2029

1.17

1.59

1.1

3.04

4.75

u/ml

1.79

111

821

Glaucoma suspect

122

981

1.25

1.59

1.1

3.43

3.18

u/ml

0.06

366

Ulcer of lower limb, not elsewhere classified

275

0.54

1.58

1.1

1.0

2.03

3.64

u/ml

—

113

Sequelae of injuries of upper limb

464

1.36

1.58

1.1

3.72

4.22

u/ml

0.14

189

Cervicobrachial syndrome

136

1108

1.23

1.58

1.1

5.09

3.60

u/ml

0.34

412

Dysplasia of cervi uteri

237

1569

1.17

1.57

1.0

1.1

3.71

5.23

u/ml

0.83

650

Benign neoplasm of middle ear and respiratory system

207

1.55

1.56

1.1

3.37

4.24

u/ml

0.20

Testicular dysfunction

160

1.64

1.56

1.0

1.1

4.51

3.05

u/ml

0.23

Disorders of vitreous body and globe

182

1490

1.19

1.55

1.0

1.1

2.61

3.48

u/ml

0.43

549

Disorders of orbit

176

1.60

1.55

1.0

1.1

2.09

4.35

u/ml

0.69

Hypertension, essential

496

3147

0.90

1.55

1.1

3.25

4.03

u/ml

0.59

204

1218

Unspecified privation

492

1.35

1.54

1.1

2.45

5.00

u/ml

1.68

200

Benign neoplasm: Ascending colon

240

1.50

1.54

1.1

1.83

2.17

u/ml

0.10

Congenital malformations of cardiac septa

579

0.70

1.54

1.0

1.1

8.75

8.84

u/ml

0.01

299

Invasive ventilation

272

0.55

1.54

1.1

0.65

5.02

u/ml

—

126

Polyuria

701

1.29

1.54

1.1

2.24

3.62

u/ml

0.78

278

Other hammer toe(s) (acquired)

341

1.40

1.54

1.1

1.0

2.30

2.41

u/ml

0.04

113

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

108

1346

0.80

1.53

1.1

7.28

5.64

u/ml

0.32

571

Localized scleroderma [morphea]

0.00

1.53

0.0

1.0

—

1.47

—

False labour

391

2179

1.13

1.53

1.1

4.07

6.09

u/ml

1.50

166

885

Outcome of delivery

176

1299

0.84

1.53

1.0

1.1

3.44

6.32

u/ml

1.76

536

Xanthelasma of eyelid

3.37

1.53

1.0

1.1

—

2.06

—

Wegener granulomatosis

0.00

1.52

0.0

1.0

—

4.51

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

373

3306

1.13

1.52

1.1

5.77

5.84

u/ml

0.02

164

1450

Congenital malformations of the respiratory system

108

1.78

1.52

1.2

1.1

1.05

8.67

u/ml

2.78

Other diseases of lip and oral mucosa

615

1.30

1.51

1.1

4.19

u/ml

0.00

219

Major anomalies of jaw size

146

1.66

1.51

1.1

5.55

7.33

u/ml

0.17

Heart failure and coronary heart disease

287

0.62

1.51

1.2

1.0

0.73

2.07

u/ml

—

114

Synovial cyst of popliteal space [Baker]

177

1.59

1.51

1.1

5.15

3.36

u/ml

0.16

Infectious mononucleosis

110

882

1.25

1.51

1.1

5.43

7.13

u/ml

0.42

396

Varicose veins of other sites

266

1.47

1.51

1.0

1.1

4.18

3.47

u/ml

0.12

113

Haemangioma and lymphangioma, any site

417

1.37

1.51

1.1

8.52

4.43

u/ml

0.54

178

Myopia

125

1017

1.23

1.50

1.1

6.38

5.68

u/ml

0.12

444

Immunodeficiencies

234

1.51

1.50

1.1

1.12

7.18

u/ml

3.85

Other specified/unspecified soft tissue disorders

131

1.69

1.49

1.0

11.34

2.11

u/ml

—

Other disorders of Eustachian tube

116

1.74

1.49

1.1

0.80

5.09

u/ml

—

Monoamine oxidase A inhibitors

452

1.35

1.49

1.0

4.04

2.89

u/ml

0.20

166

Benign paroxysmal vertigo

122

990

1.23

1.49

1.0

1.1

2.86

3.33

u/ml

0.14

378

Other diseases of gallbladder

101

1.79

1.49

1.1

1.0

0.30

4.04

u/ml

—

Benign neoplasm: Colon

164

1342

1.20

1.48

1.1

1.0

2.72

2.83

u/ml

0.04

488

MS-disease / Multiple Sclerosis

512

0.68

1.48

1.0

1.1

2.89

3.41

u/ml

0.12

213

Juvenile osteochondrosis

243

1.49

1.48

1.0

1.1

5.21

7.21

u/ml

0.18

101

Contraceptive management

403

2526

1.12

1.48

1.1

5.16

5.53

u/ml

0.12

158

1038

Shoulder lesions

487

2683

1.11

1.48

1.1

2.36

3.87

u/ml

2.26

184

1034

Medicines for HER+ breast cancer

115

1381

0.81

1.47

1.1

1.84

3.48

u/ml

1.90

512

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

102

882

0.80

1.47

1.1

1.0

2.75

2.73

u/ml

0.01

329

Exposure to other and unspecified animate mechanical forces

203

1.54

1.47

1.1

3.28

5.94

u/ml

0.72

Open wound of hip and thigh

179

1.58

1.46

1.0

1.1

2.47

5.22

u/ml

0.86

Concussion

429

3329

1.12

1.46

1.1

5.32

5.31

u/ml

0.00

193

1487

Heterophoria

550

1.32

1.45

1.1

6.70

5.48

u/ml

0.23

249

Leiomyoma of uterus

359

2302

0.89

1.45

1.1

3.50

u/ml

0.00

125

870

Alcoholic liver disease

241

0.54

1.45

1.1

1.0

16.33

3.19

u/ml

—

Muscle strain

148

1.63

1.45

1.1

4.89

3.45

u/ml

0.17

Colonic or urogenital fistula

152

1266

1.20

1.44

1.1

4.71

3.58

u/ml

0.26

502

Generalized epilepsy, strict definition

172

1.59

1.44

1.0

1.1

8.72

8.54

u/ml

0.01

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

212

1.52

1.44

1.2

1.1

4.04

5.93

u/ml

0.36

Viral hepatitis, IBD co-morbidity

377

0.63

1.44

1.2

1.1

9.38

3.72

u/ml

0.48

155

Presence of cardiac and vascular implants and grafts

752

0.77

1.44

1.0

3.88

3.00

u/ml

0.11

301

Superficial injury of hip and thigh

524

1.32

1.44

1.1

6.29

4.32

u/ml

0.48

219

Use of pramipexole

638

1.29

1.43

1.1

1.87

2.91

u/ml

0.76

237

Erosion of teeth, including avohilmo

178

1454

1.19

1.43

1.1

1.0

6.18

5.99

u/ml

0.03

598

Nausea and vomiting

166

1372

1.19

1.43

1.1

5.18

6.86

u/ml

0.49

629

Nonorganic sleeping disorders, excluding more controls

158

1323

1.20

1.43

1.1

4.25

4.71

u/ml

0.17

550

414

0.66

1.43

1.1

5.70

10.31

u/ml

0.88

250

Trigger finger

586

1.30

1.43

1.1

1.0

2.14

3.24

u/ml

0.47

205

Bilateral sagittal split ramus osteotomy operation

237

1.49

1.43

1.1

1.67

5.70

u/ml

2.34

Care involving dialysis

265

0.56

1.42

1.0

1.1

7.28

5.13

u/ml

—

117

Ulcer of vagina/vulva

118

1.71

1.42

1.2

1.0

15.68

7.95

u/ml

—

Fracture at wrist and hand level

251

2183

1.15

1.41

1.1

8.09

4.93

u/ml

0.81

124

946

Pericarditis

103

1.76

1.41

1.1

1.0

1.24

4.78

u/ml

—

Disorders of vestibular function (Vertigo)

205

1745

1.17

1.40

1.0

1.1

4.14

3.43

u/ml

0.26

665

Congenital malformations, deformations and chromosomal abnormalities

570

4983

1.10

1.40

1.0

1.1

5.27

5.71

u/ml

0.24

264

2147

Infections of the skin and subcutaneous tissue

447

4014

1.11

1.40

1.1

8.66

5.24

u/ml

1.46

206

1756

COPD, hospital admissions 3, with asthma pneumonia sepsis

329

1.37

1.40

1.1

1.0

6.64

2.48

u/ml

0.54

125

372

0.64

1.40

1.2

1.1

5.67

10.43

u/ml

0.77

223

Other systemic involvement of connective tissue (FG)

139

1145

1.21

1.39

1.1

3.63

4.78

u/ml

0.34

440

Myocardial infarction

104

926

0.81

1.39

1.1

1.0

1.40

2.63

u/ml

1.28

351

Other predominantly sexually transmitted diseases, not elsewhere classified

181

1539

1.18

1.39

1.1

3.83

5.12

u/ml

0.55

656

Melanocytic naevi

209

1797

1.17

1.39

1.0

1.1

6.12

4.92

u/ml

0.35

752

Cardiac arrhythmias

504

3671

0.91

1.39

1.1

4.12

4.74

u/ml

0.33

218

1506

Pulmonary embolism

792

1.25

1.39

1.1

5.93

3.16

u/ml

0.41

302

Other puerperal infections

776

1.26

1.39

1.1

6.66

4.28

u/ml

0.38

322

Acute lymphadenitis

407

1.36

1.38

1.1

5.58

5.38

u/ml

0.03

170

Impetigo

356

1.39

1.38

1.2

1.1

11.09

4.87

u/ml

1.43

171

Poor fetal growth

104

1283

0.81

1.38

1.1

3.93

4.67

u/ml

0.18

525

Mental and behavioural disorders due to sedatives or hypnotics

397

0.65

1.38

1.0

1.1

5.50

5.01

u/ml

0.05

158

Angina pectoris

133

1086

0.83

1.38

1.1

1.0

0.88

2.52

u/ml

3.36

403

Impingement syndrome of shoulder

114

928

1.23

1.37

1.1

1.0

3.47

3.48

u/ml

0.00

331

Pulmonary heart disease

793

1.25

1.37

1.1

5.93

3.15

u/ml

0.41

303

Other systemic involvement of connective tissue

139

1155

1.21

1.37

1.1

3.63

4.56

u/ml

0.27

455

Benign neoplasm: Ascending colon

247

1.46

1.37

1.1

1.83

3.00

u/ml

0.41

Disturbance of activity and attention

149

1232

1.20

1.37

1.1

12.88

7.39

u/ml

0.73

616

Other bursopathies

416

1.35

1.37

1.1

4.92

3.35

u/ml

0.25

155

Haemangioma and lymphangioma, any site

425

1.35

1.36

1.1

8.52

4.50

u/ml

0.53

184

Poisoning by drugs, medicaments and biological substances

158

1871

0.84

1.36

1.1

9.95

5.49

u/ml

1.08

792

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

1.36

0.0

1.1

—

4.44

—

Habitual aborter

191

1.54

1.36

1.0

1.1

3.00

3.32

u/ml

0.05

Polyarthrosis

457

1.32

1.35

1.0

4.71

2.54

u/ml

0.22

142

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

350

2491

0.89

1.35

1.1

2.24

4.33

u/ml

3.65

142

974

Tumor necrosis factor alpha inhibitors

1058

0.79

1.35

1.0

1.1

2.86

5.73

u/ml

1.27

435

Other shoulder lesions

478

1.32

1.35

1.1

1.41

3.68

u/ml

1.72

178

Amblyopia ex anopsia

282

1.43

1.34

1.1

18.14

9.81

u/ml

0.33

142

Non-selective monoamine reuptake inhibitors

185

1532

1.17

1.34

1.1

1.0

3.65

2.96

u/ml

0.19

561

Retinal detachments and breaks

116

949

1.22

1.34

1.1

1.0

4.46

3.31

u/ml

0.28

347

Poisoning by medicine

143

1704

0.84

1.33

1.1

9.97

5.37

u/ml

1.04

726

Tic and related disorders

113

1.71

1.33

1.1

1.66

8.18

u/ml

2.54

Anogenital herpesviral [herpes simplex] infection

506

1.31

1.32

1.1

2.10

3.92

u/ml

1.10

200

Other female pelvic inflammatory diseases

104

843

1.24

1.32

1.1

1.44

3.62

u/ml

2.59

325

Sequelae of other external causes

184

1.53

1.32

1.1

2.69

5.29

u/ml

0.65

Other congenital malformations

745

1.25

1.32

1.1

5.84

6.83

u/ml

0.25

349

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

317

2815

1.13

1.31

1.1

4.17

4.37

u/ml

0.06

137

1117

Acute alcohol intoxication, ICD10

1121

0.80

1.31

1.1

8.03

5.65

u/ml

0.46

455

Used for control exclusion in common control thyroid runs

883

4811

0.93

1.31

1.1

5.79

5.64

u/ml

0.06

369

2116

L04AA Selective immunosuppressants

1209

0.81

1.31

1.1

1.35

4.31

u/ml

6.37

485

Other disorders of binocular vision

1.87

1.31

1.1

5.44

6.80

u/ml

—

Antenatal screening

250

1610

0.87

1.31

1.1

6.69

6.62

u/ml

0.02

100

672

Injuries to the knee and lower leg

996

5325

1.07

1.31

1.1

5.12

5.32

u/ml

0.08

430

2251

Nontraumatic intracranial haemmorrhage

416

0.67

1.31

1.1

6.26

3.46

u/ml

—

170

Postmenopausal bleeding

108

479

1.24

1.30

1.0

4.05

2.59

u/ml

0.24

166

Chronic suppurative otitis media

343

1.38

1.30

1.1

4.75

8.26

u/ml

0.81

150

Long labour

266

2043

1.14

1.29

1.1

4.77

5.50

u/ml

0.21

112

810

Benign lipomatous neoplasm

141

1181

1.20

1.29

1.0

1.1

5.67

3.28

u/ml

0.55

456

Malignant neoplasm of skin

124

1126

0.83

1.29

1.1

1.0

3.06

2.45

u/ml

0.21

410

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

535

3812

0.91

1.29

1.1

2.55

3.99

u/ml

2.49

214

1509

Other abnormal uterine and vaginal bleeding

135

801

1.20

1.28

1.1

2.04

4.53

u/ml

1.58

322

Keratoconus

122

1.65

1.28

1.1

16.52

3.56

u/ml

1.19

Urethritis and urethral syndrome

1.80

1.27

1.2

1.1

1.59

5.25

u/ml

—

Prolapse and hernia of ovary and fallopian tube

2.76

1.27

1.0

1.1

—

1.35

—

Use of hypnotics and sedatives

698

4366

0.92

1.26

1.1

3.75

4.47

u/ml

0.51

286

1768

Testicular hypofunction

146

1.59

1.26

1.0

1.1

4.30

3.11

u/ml

—

Effects of foreign body entering through natural orifice

171

1461

1.17

1.26

1.1

4.54

5.70

u/ml

0.46

646

Thoracic aortic aneurysm

277

1.41

1.26

1.1

2.67

2.59

u/ml

0.02

105

Benign neoplasm: Other and unspecified parts of mouth

1.75

1.25

1.0

1.1

2.38

2.99

u/ml

—

Open wound of wrist and hand

330

2922

1.12

1.25

1.1

6.94

4.98

u/ml

0.82

137

1253

Disorders of eyelid in diseases classified elsewhere

123

1.64

1.24

1.3

1.0

14.19

4.83

u/ml

0.57

Car occupant injured in other and unspecified transport accidents

160

1362

1.18

1.24

1.1

6.48

5.49

u/ml

0.22

576

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

110

920

0.82

1.24

1.1

1.0

2.58

2.84

u/ml

0.08

346

Septal defects

549

0.73

1.24

1.0

1.1

8.75

8.64

u/ml

0.01

284

Generalized skin eruption due to drugs and medicaments

171

1.53

1.23

1.0

1.1

5.79

5.98

u/ml

0.02

Fracture of shoulder and upper arm

149

1754

0.85

1.23

1.1

5.44

6.43

u/ml

0.18

762

Benign neoplasm of middle ear and respiratory system

220

1.46

1.23

1.1

3.37

4.85

u/ml

0.36

Tic and related disorders

116

1.66

1.23

1.1

1.66

8.42

u/ml

2.79

L04AC Interleukin inhibitors

277

0.61

1.23

1.0

1.1

1.63

4.36

u/ml

—

109

Sequelae of injuries, of poisoning and of other consequences of external causes

151

1281

1.18

1.22

1.1

3.94

3.88

u/ml

0.02

512

Other congenital malformations of the digestive system

354

1.36

1.22

1.1

8.06

8.87

u/ml

0.10

189

Drug-induced cataract

1.81

1.21

1.1

1.0

16.57

4.96

u/ml

—

Other reaction to severe stress, and adjustment disorders

349

3138

1.11

1.21

1.1

7.38

5.04

u/ml

1.06

156

1325

Gonarthrosis,primary

338

2372

0.90

1.21

1.1

2.47

3.15

u/ml

0.56

138

855

Benign neoplasm: Skin of eyelid, including canthus

469

1.30

1.21

1.1

9.55

3.65

u/ml

0.61

180

Other disorders of binocular movement

148

1.57

1.21

1.2

1.1

6.41

7.29

u/ml

0.10

Polyp of the female genital tract

217

1097

1.15

1.21

1.1

2.29

3.52

u/ml

0.84

428

Parkinson's disease, including avohilmo

201

0.55

1.20

1.0

0.46

1.87

u/ml

—

Bullous disorders

140

1.58

1.20

1.0

1.1

24.89

3.44

u/ml

1.31

Acute alcohol intoxication

106

1282

0.83

1.19

1.0

1.1

7.59

5.27

u/ml

0.52

510

Localized skin eruption due to drugs and medicaments

2.33

1.19

1.0

1.1

—

5.23

—

Insomnia

130

1092

1.19

1.1

4.46

5.34

u/ml

0.28

442

Other maternal disorders predominantly related to pregnancy

555

3204

1.09

1.19

1.1

5.48

5.41

u/ml

0.02

220

1294

Complications of medical and surgical care

444

3839

1.10

1.19

1.1

3.91

4.54

u/ml

0.33

192

1535

Viral infections characterized by skin and mucous membrane lesions

288

2563

1.12

1.19

1.1

6.73

5.44

u/ml

0.47

129

1113

Other arthrosis

280

1776

1.13

1.18

1.1

2.96

3.49

u/ml

0.27

126

634

Helminthiases

1.89

1.18

1.2

1.1

15.05

4.94

u/ml

—

Fitting and adjustment of other devices

101

769

1.22

1.18

1.0

4.37

3.55

u/ml

0.10

291

Diseases of arteries, arterioles and capillaries (FINNGEN)

721

0.80

1.18

1.0

2.63

3.75

u/ml

0.42

268

Other diseases of anus and rectum

129

1082

1.19

1.18

1.1

5.26

3.95

u/ml

0.25

425

Other disorders of the musculoskeletal system and connective tissue

480

1.29

1.18

1.0

1.1

1.79

3.31

u/ml

1.07

182

Other disorders of optic disc

2.02

1.17

1.4

1.1

20.86

3.62

u/ml

—

Haemangioma, any site

376

1.33

1.17

1.1

8.51

4.73

u/ml

0.40

165

Rash and other nonspecific skin eruption

437

1.31

1.17

1.1

6.23

5.14

u/ml

0.19

185

Tooth agenesis EXCLUDE clefts and syndromes

403

1.33

1.16

1.1

8.40

7.81

u/ml

0.06

196

Other and unspecified erythematous conditions

102

1.68

1.16

1.1

3.04

4.82

u/ml

—

Malignant neoplasm of breast, HER-negative

646

0.76

1.16

1.0

1.1

4.38

2.80

u/ml

0.27

233

Other diseases of jaws

299

1.38

1.16

1.0

1.1

2.04

4.94

u/ml

1.43

117

Other and unspecified injuries of wrist and hand

224

1.44

1.15

1.1

8.05

5.60

u/ml

0.24

Sacrococcygeal disorders, not elsewhere classified

142

1.56

1.14

1.0

1.1

1.53

4.04

u/ml

—

Acute nasopharyngitis (common cold)

683

1.24

1.14

1.0

4.48

4.40

u/ml

0.02

280

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

0.00

1.14

0.0

1.1

—

4.35

—

Fall on same level

924

5502

0.94

1.14

1.1

4.86

5.54

u/ml

0.41

427

2337

Other heart diseases, wide

711

4740

0.93

1.13

1.1

4.04

5.24

u/ml

1.02

314

1989

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

554

1.27

1.13

1.0

1.1

1.47

3.68

u/ml

2.24

209

severe traumatic brain injury, does not include concussion

587

0.75

1.13

1.0

1.1

4.01

3.90

u/ml

0.02

241

Diseases of inner ear

245

2122

1.13

1.0

1.1

3.60

3.69

u/ml

0.03

823

Aplastic and other anaemias

116

1312

0.84

1.13

1.0

1.1

6.17

3.69

u/ml

0.69

535

Benign neoplasm: Transverse colon

183

1.48

1.13

1.1

0.73

2.80

u/ml

—

Caught, crushed, jammed or pinched in or between objects

284

1.38

1.13

1.1

11.13

4.57

u/ml

1.26

119

Other disorders of male genital organs

167

1.51

1.12

1.0

1.1

0.96

4.63

u/ml

2.49

Infections of genitourinary tract in pregnancy

676

0.77

1.12

1.1

2.82

4.00

u/ml

0.55

276

Retinal detachment with retinal break

301

1.37

1.12

1.0

1.1

8.23

2.54

u/ml

0.51

116

Sequelae of infectious and parasitic diseases

327

1.35

1.12

1.2

1.1

15.33

4.14

u/ml

0.83

121

Streptococcal septicaemia

258

0.62

1.12

1.1

1.42

5.59

u/ml

—

118

Meniscus derangement

343

2114

1.11

1.12

1.1

3.44

3.72

u/ml

0.11

145

783

Scleritis

1.98

1.12

1.0

1.1

6.01

5.14

u/ml

—

Other and unspecified local infections of skin and subcutaneous tissue

414

1.31

1.12

1.0

1.1

10.11

4.65

u/ml

0.81

164

Guttate psoriasis

1.98

1.12

1.1

1.34

4.52

u/ml

—

Other diseases of peritoneum

143

1.55

1.11

1.0

1.51

3.26

u/ml

—

Other, unspecified and serous retinal detachments

1.79

1.11

1.0

1.1

18.44

2.81

u/ml

—

Acute generalized exanthematous pustulosis

184

1.47

1.11

1.0

1.1

5.79

7.05

u/ml

0.16

Glucosamine medication

119

795

1.20

1.11

1.0

2.05

2.69

u/ml

0.34

281

Tic disorders

112

1.63

1.10

1.1

1.64

7.90

u/ml

2.56

Other infective otitis externa

243

1.41

1.09

1.1

11.30

5.63

u/ml

0.47

Myocardial infarction, strict

833

0.82

1.09

1.1

1.0

1.35

2.79

u/ml

1.39

314

Unspecified fall

304

2711

1.11

1.09

1.1

7.21

5.80

u/ml

0.50

149

1203

Speech and linguistic disorders, excluding more controls

106

832

1.21

1.08

1.1

7.05

8.23

u/ml

0.26

425

Gout, idiopatic and unspecified

422

0.71

1.08

1.0

1.16

2.76

u/ml

1.24

163

Striae atrophicae

1.89

1.08

1.1

0.38

2.70

u/ml

—

malignant neoplasm of female genital organs

363

0.69

1.08

1.0

1.1

2.23

3.01

u/ml

0.34

133

Puerperal sepsis

639

1.24

1.08

1.1

2.33

3.11

u/ml

0.31

225

Inflammatory disease of cervix uteri

227

1.41

1.08

1.1

0.85

2.44

u/ml

1.21

Coxarthrosis [arthrosis of hip](FG)

164

1371

0.86

1.07

1.1

1.35

3.20

u/ml

2.97

498

Volume depletion

218

0.59

1.07

1.2

1.1

9.03

6.12

u/ml

—

Delayed puberty

1.74

1.07

1.1

18.59

9.92

u/ml

—

Benzodiazepine use

662

5058

0.93

1.07

1.1

4.94

4.72

u/ml

0.10

288

2065

Family history of other conditions

1.73

1.06

1.1

3.26

6.65

u/ml

—

Medical abortion

557

2795

1.08

1.06

1.1

5.35

5.34

u/ml

0.00

233

1131

Pulmonary heart disease, diseases of pulmonary circulation

105

876

1.20

1.05

1.1

5.45

3.67

u/ml

0.26

341

Delivery, wide proxy

233

1400

0.88

1.05

1.1

6.57

7.02

u/ml

0.11

110

623

Convulsions, not elsewhere classified

142

1631

0.86

1.05

1.1

9.29

6.14

u/ml

0.38

754

Obsessive-compulsive disorder

624

1.24

1.05

1.0

1.1

7.56

6.34

u/ml

0.14

271

Fall on same level involving ice and snow

357

3245

1.10

1.04

1.0

1.1

7.25

4.89

u/ml

0.66

159

1346

Focal epilepsy

1131

0.83

1.04

1.1

6.38

5.43

u/ml

0.13

498

Melanocytic naevi

209

1844

1.14

1.04

1.0

1.1

6.12

4.98

u/ml

0.33

767

Ankyloglossia

212

1.43

1.04

1.1

7.43

9.09

u/ml

0.22

126

Parkinson's disease

191

0.58

1.03

1.0

0.46

1.82

u/ml

—

Other inflammation of vagina/vulva

272

1.37

1.03

1.0

5.09

5.01

u/ml

0.01

100

138

1.53

1.03

1.1

31.13

2.80

u/ml

—

Melanocytic naevi of other and unspecified parts of face

289

1.36

1.03

1.1

5.28

5.94

u/ml

0.07

116

Budesonide

697

1.22

1.03

1.0

1.1

3.94

3.54

u/ml

0.09

252

Post-traumatic stress disorder

780

1.21

1.02

1.1

8.64

5.98

u/ml

0.20

335

Falls/tendency to fall

1044

4937

1.06

1.02

1.1

5.49

5.44

u/ml

0.02

477

2075

Digestive system disorders of fetus and newborn

0.00

1.02

0.0

1.2

—

7.43

—

Presence of other devices

535

1.25

1.02

1.1

1.0

1.97

3.65

u/ml

0.60

201

Other noninflammatory disorders of vulva and perineum

518

1.26

1.02

1.1

8.01

3.90

u/ml

0.47

212

Fracture of lumbar spine and pelvis

598

0.77

1.02

1.1

3.54

3.99

u/ml

0.07

236

Other congenital malformations of tongue, mouth and pharynx

171

1.48

1.02

1.1

1.2

9.17

9.42

u/ml

0.02

106

Other disorders of teeth and supporting structures

108

908

1.19

1.01

1.1

2.42

5.28

u/ml

1.38

340

Pregnancy, childbirth and the puerperium

204

1212

0.88

1.01

1.1

6.44

7.27

u/ml

0.21

545

Obesity

482

4406

1.08

1.01

1.1

5.70

4.67

u/ml

0.31

202

1795

Supervision of high-risk pregnancy

215

1468

0.88

1.01

1.1

6.28

6.54

u/ml

0.05

594

Other local infections of skin and subcutaneous tissue

439

1.28

1.01

1.0

1.1

9.73

4.80

u/ml

0.73

173

Maxillary retrognathism

131

1.54

1.00

1.2

1.1

4.07

6.98

u/ml

—

Other and unspecified injuries of ankle and foot

282

1.36

1.00

1.1

7.51

4.71

u/ml

0.34

126

Glomerular disorders in diseases classified elsewhere

415

0.72

1.00

1.0

1.1

2.46

4.34

u/ml

0.67

173

Hyperkinetic disorders

156

1337

1.16

1.00

1.1

12.86

7.44

u/ml

0.78

666

Ovarian hyperstimulation (induction)

164

1.48

1.00

1.0

1.1

10.57

3.62

u/ml

—

Cardiovascular diseases

818

4183

1.07

1.00

1.1

4.59

6.18

u/ml

1.43

354

1860

Carcinoma in situ of breast, intraductal

262

0.65

1.00

1.0

1.1

5.93

2.63

u/ml

—

Benign neoplasm: Other and unspecified parts of mouth

1.62

1.00

1.0

1.1

2.38

2.41

u/ml

—

Supervision of normal pregnancy

245

1569

0.89

1.00

1.1

7.51

6.63

u/ml

0.19

648

Coeliac disease

691

1.22

1.00

1.1

7.57

5.25

u/ml

0.39

294

Erythema nodosum

115

1.57

1.00

1.1

1.14

7.42

u/ml

2.01

Haemangioma, any site

387

1.30

0.99

1.1

8.51

4.72

u/ml

0.41

169

Viral pneumonia (known virus, not influenza)

1.72

0.99

1.2

1.1

4.57

5.41

u/ml

—

Persistent delusional disorders

297

0.67

0.99

1.1

9.15

3.64

u/ml

—

121

Explicit bacterial Sepsis

379

0.71

0.99

1.1

4.90

5.63

u/ml

—

167

Fall on and from stairs and steps

139

1197

1.16

0.99

1.1

5.19

4.11

u/ml

0.31

493

Behavioural syndromes associated with physiological disturbances and physical factors

304

2750

1.11

0.99

1.1

4.27

6.09

u/ml

1.23

138

1218

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

200

0.60

0.98

1.0

2.37

4.46

u/ml

—

Endometriosis of ovary

124

1057

1.17

0.97

1.1

2.35

3.62

u/ml

0.89

423

Malignant neoplasm of oropharynx

0.00

0.97

0.0

1.0

—

5.46

—

Temporal arteritis

0.00

0.97

0.0

1.1

—

1.89

—

Other/unspecified disorders of vestibular function

1.64

0.97

1.1

1.0

0.80

4.27

u/ml

—

Other and unspecified injuries of lower leg

442

1.27

0.97

1.1

14.27

5.88

u/ml

0.35

189

Benign neoplasm of colon, rectum, anus and anal canal

196

1584

0.88

0.96

1.1

3.58

3.27

u/ml

0.08

598

Pilonidal cyst

704

0.79

0.96

1.1

15.75

4.80

u/ml

0.42

287

Pyogenic arthritis

207

1.41

0.96

1.1

2.04

4.93

u/ml

1.00

Perineal laceration during delivery

163

1659

0.87

0.96

1.1

4.49

6.00

u/ml

0.60

682

Other mental disorders due to brain damage and dysfunction and to physical disease

211

0.61

0.96

1.0

1.1

0.99

2.55

u/ml

—

Premature rupture of membranes

265

1751

1.12

0.96

1.1

4.36

5.60

u/ml

0.44

729

Postpartum hemorraghe, parous women as controls

268

2113

1.11

0.96

1.1

3.94

4.57

u/ml

0.24

833

Otitis externa, unspecified

622

1.23

0.96

1.1

3.69

4.91

u/ml

0.21

264

Congenital malformations of the urinary system

376

0.71

0.96

1.0

1.1

12.02

7.40

u/ml

0.37

184

Malignant neoplasm of digestive organs

726

0.80

0.96

1.0

4.44

2.67

u/ml

0.46

283

Achilles tendinitis

407

1.28

0.96

1.1

5.35

2.95

u/ml

0.36

152

Other disorders of conjunctiva

354

1.30

0.96

1.0

1.1

3.12

2.94

u/ml

0.05

134

Other/unspecified rheumatoid arthritis

318

0.69

0.95

1.2

1.1

2.03

3.06

u/ml

—

122

Other diseases of intestines

945

5190

1.06

0.95

1.1

4.92

5.46

u/ml

0.34

366

2266

Problems related to lifestyle

703

0.79

0.95

1.0

1.1

5.15

5.38

u/ml

0.03

287

Alcoholic gastritis

0.00

0.95

0.0

1.0

—

3.12

—

Coxarthrosis

159

1236

0.87

0.95

1.1

1.39

3.20

u/ml

2.67

433

Giant cell arteritis with polymyalgia rheumatica

0.00

0.95

0.0

1.1

—

1.80

—

Toxic effect of contact with venomous animals

191

1.42

0.95

1.0

1.1

9.85

4.70

u/ml

—

Crowding of teeth, including avohilmo

132

938

1.17

0.94

1.1

10.57

8.70

u/ml

0.21

479

Other and unspecified follicular disorders

183

1.43

0.94

1.1

1.0

2.53

3.39

u/ml

0.19

Obesity and other hyperalimentation

482

4420

1.08

0.94

1.1

5.70

4.71

u/ml

0.29

202

1798

Focal epilepsy, mode (most common among epilepsy diagnosis)

954

0.83

0.93

1.1

7.00

5.56

u/ml

0.18

415

Lesion of plantar nerve

183

1.43

0.93

1.1

1.22

3.75

u/ml

1.18

Oral leukoplakia

2.23

0.93

1.2

1.1

—

4.81

—

Hydronephrosis

386

0.72

0.93

1.1

1.46

4.75

u/ml

—

157

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

363

0.71

0.93

1.1

8.09

4.04

u/ml

0.28

150

Sicca syndrome [Sjögren]

312

1.32

0.93

1.0

1.1

1.71

4.16

u/ml

1.36

116

Divergent concomitant strabismus

454

0.75

0.93

1.0

1.1

3.76

4.02

u/ml

0.04

178

Disorders of mineral metabolism

260

1.35

0.93

1.0

1.1

4.29

5.00

u/ml

0.07

111

Systemic sclerosis (FG)

1.72

0.93

1.1

1.09

6.91

u/ml

—

Sacroiliitis, not elsewhere classified

330

1.31

0.93

1.0

1.1

1.86

4.50

u/ml

1.40

132

Cardiomyopathy (excluding other)

338

0.71

0.91

1.1

1.0

9.95

4.26

u/ml

—

135

Astigmatism

428

1.27

0.91

1.1

5.37

7.58

u/ml

0.49

212

Other misadventures during surgical and medical care

1.76

0.90

1.2

1.1

0.25

4.29

u/ml

—

Radiculopathy

509

1.24

0.90

1.1

4.58

2.89

u/ml

0.26

180

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

676

5058

0.94

0.90

1.1

3.79

5.47

u/ml

2.38

335

2114

Alopecia areata

143

1.48

0.90

1.0

1.1

14.03

7.91

u/ml

—

Other arrhythmias

429

3033

1.08

0.89

1.1

3.51

4.80

u/ml

0.87

176

1212

Other disorders of veins

207

1846

1.12

0.89

1.1

3.11

3.44

u/ml

0.12

697

Other complications of labour and delivery, not elsewhere classified

116

1298

0.86

0.89

1.1

9.20

6.20

u/ml

0.49

532

Tramadol

535

3201

1.08

0.89

1.1

1.0

3.35

4.19

u/ml

0.49

236

1289

Inguinal hernia, bilateral

219

1.37

0.89

1.0

1.1

2.79

3.99

u/ml

0.35

Later onset COPD

151

1.40

0.89

1.0

0.47

1.61

u/ml

—

Antihypertensive medication - note that there are other indications

785

4047

1.06

0.89

1.1

6.18

5.98

u/ml

0.07

342

1796

Dental caries

137

1557

0.87

0.89

1.2

1.1

3.80

6.71

u/ml

1.84

668

Alcohol-induced chronic pancreatitis

206

0.63

0.89

1.0

2.15

2.99

u/ml

—

Mixed and other personality disorders

562

0.78

0.88

1.1

4.11

4.09

u/ml

0.00

230

Cardiomyopathies, Primary/intrinsic

324

0.71

0.88

1.1

1.0

9.95

4.15

u/ml

—

131

Other and unspecified visual disturbances

377

1.28

0.88

1.2

1.1

3.06

4.29

u/ml

0.43

148

Other disorders starting during childhood or adolescence

707

1.20

0.87

1.1

10.27

9.20

u/ml

0.13

380

Postprocedural disorders of nervous system

572

0.78

0.87

1.0

1.1

4.64

3.83

u/ml

0.13

233

Other acquired deformities of musculoskeletal system and connective tissue

186

1.40

0.87

1.0

1.1

3.01

3.25

u/ml

—

Polyneuropathies and other disorders of the peripheral nervous system

575

1.22

0.87

1.1

4.06

3.81

u/ml

0.04

222

Glomerular diseases

749

0.81

0.87

1.0

1.1

2.16

4.33

u/ml

1.68

317

Parkinson's disease, excluding more controls

176

0.61

0.86

1.0

0.46

1.05

u/ml

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

308

2783

1.10

0.86

1.1

5.74

5.99

u/ml

0.05

150

1242

Chronic periodontitis, complicated

264

0.68

0.86

1.1

6.15

3.04

u/ml

—

Reactive arthropathies

432

1.25

0.86

1.0

1.1

3.78

4.64

u/ml

0.18

152

Aortic aneurysm

363

1.27

0.85

1.0

2.26

2.64

u/ml

0.14

146

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cat dander IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS